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Alzheimer’s disease (AD) is the major cause of dementia and is characterized by neuronal death 
and brain atrophy. The amyloid β (Aβ) peptide is tightly associated with neuronal dysfunction 
during AD, but the molecular mechanism underlying the neurotoxic effect of Aβ is poorly 
understood. Extracellular fibrillar deposits (plaques) of Aβ were initially believed to be the cause 
of AD, but currently there is overwhelming evidence that the prefibrillar Aβ oligomers are the 
major toxic entities. Structural characterization of Aβ oligomers and fibrils is important for 
understanding the structural features determining the toxic potency of the peptide. This project 
has studied the aggregation and accompanying structural transitions of Aβ, a naturally occurring 
hypertoxic species, i.e. pyroglutamylated Aβ, and their combination, using biophysical 
approaches (circular dichroism, fluorescence, infrared spectroscopy). In addition, aggregation 
and structure of overlapping peptide fragments have been studied to identify the specific stretch 
of Aβ that serves as seeding region initiating the aggregation and fibril formation by the full-
length Aβ peptide. These studies elucidate the structural features of Aβ responsible for the 
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CHAPTER 1: INTRODUCTION 
 
1.1 Amyloid β Peptide Structure and Toxicity 
 
Alzheimer’s disease (AD) is a neurodegenerative pathology that mostly affects elderly 
people and causes cognitive decline and dementia. The underlying pathology is brain atrophy, 
synaptic loss and neuronal cell death [1]. At the molecular level, extracellular fibrillar deposits 
(plaques) formed by the amyloid β (Aβ) peptide and intracellular accumulation of neurofibrillary 
tangles of tau protein are the major histopathological traits of AD [2-4]. 
Aβ plaques were initially believed to cause the onset and progression of AD, but further 
studies provided strong evidence that the prefibrillar oligomeric form of Aβ, rather than fibrillar 
aggregates, constitutes the main cytotoxic entity [5]. The molecular mechanism by which Aβ 
oligomers kill neuronal cells is yet to be identified, but the extensive research has delineated 
several pathways. One of the prevalent mechanisms of Aβ neurotoxicity is formation of pores or 
ion channels in cellular membranes, causing dysregulation of cellular homeostasis and neuronal 
cell death [6-8]. For example, binding of Aβ to the endoplasmic reticulum (ER) and pore 
formation results in Ca2+ release, followed by abnormal activation of certain cytosolic enzymes 
and apoptotic cell death [9-13]. Recruitment of Aβ to mitochondria and altered mitochondrial 
dynamics has been identified as another mechanism of apoptotic neuronal cell death during AD 
[10,14-17]. Lastly, a variety of unrelated receptors bind Aβ, leading to disruption of cell 
signaling pathways and cellular damage through apoptosis or necrosis [18-20]. 
Aβ is derived from a bitopic protein in neuronal membrane, amyloid precursor protein 
(APP), by β- and γ-secretases, which cleave APP in the transmembrane and extracellular 
juxtamembrane regions [21]. The pathogenicity of Aβ depends on many factors, specifically the 
peptide species, their aggregation state, the composition of the assemblies, and the peptide's 
 2 
secondary, tertiary, and quaternary structures. Due to poor sequence specificity of the secretases, 
as well as because of further proteolytic processing, Aβ species of various lengths are produced 
in human brain. The 40 and 42-amoino acid residue peptides (Aβ1-40 and Aβ1-42 are) are the 
prevalent forms. APP can also be cleaved by -secretase, which does not produce A (Figure 
1.1) 
It has been reported that the Aβ oligomers undergo a conformational switch from random 
coil or α-helix to highly toxic β-sheet structure [22]. Successful design of molecules capable of 
interacting with  
 
                                         
Figure 1. 1: The non-amyloidogenic and amyloidogenic pathways of APP processing. Cleavage 
of APP by 𝛼-secretase produces sAPP𝛼 which is harmless, whereas cleavage of APP by β- and  
γ-secretases produces the amyloidogenic Aβ peptide. Source: Petra E. Spies et al. [23]. 
Aβ as inhibitors of aggregation or as inhibitors of membrane pore formation may lead to 
fundamental progress in the improvement of anti-Alzheimer therapies [24,25]. However, such 
efforts will require a detailed knowledge of the structural features of various toxic forms of Aβ 
peptides. The major objective of this project is to help accumulate such knowledge. Specifically, 
the project is designed to achieve a mechanistic understanding of the conformational changes of 
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Aβ peptide in aqueous environment by using biophysical approaches, such as circular dichroism 
(CD), Fourier transform infrared spectroscopy (FTIR) and fluorescence spectroscopy (FS). 
1.2 Different Forms of Aβ 
 
The full-length Aβ1-42 with sequence NH2-DAEFRHDSGYEVHH QKLVFFAEDVGSN 
KGAIIGLMVGGVVIA-COOH is amphiphilic as its N-terminal half is hydrophilic and the C-
terminal half is mostly nonpolar. Interaction of Aβ1-42 with ER membrane has been shown to 
activate the ryanodine receptor ion channel and dysregulate intracellular calcium homeostasis 
[26, 27]. Lin et al. [28] have shown that Aβ1-42 has globular structure that forms multimeric 
channel-like assemblies in a planar lipid bilayer. Alternatively, it has been reported that Aβ forms 
fibrils consisting of antiparallel β-sheets and β-hairpins at residues 24 to 29, with intramolecular 
hydrogen bonding between β-strands on either side of a β-turn and a bend in residues 23 to 26 
[29]. 
Aβ1–40 is the most abundant Aβ species and possesses significant neurotoxicity. Coles et 
al. [30] reported that the first 14 residues of Aβ1–40 are structurally disordered in the fibrils, the 
rest of the protein adopts an α-helical conformation between residues 15 and 36 with a kink or 
hinge at 25−27. Aβ1–40  contains central (residues 17-21) and C-terminal (residues 30-40) 
hydrophobic segments. Formation of parallel β-sheet structure might be hampered by 
electrostatic repulsions between similar charges. 
Recently, Alomar et al have done an observational study of Aβ1–42  and Aβ1–40  in the 
cerebrospinal fluid during pregnancy. There it has been documented the higher concentrations of 
Aβ1-42  in cerebrospinal fluid of third trimester pregnancies and correlations between the beta-
amyloid ratio and the vascular endothelial growth factor support the hypothesis that beta-amyloid 
peptides are involved in complex adaptive brain alterations during pregnancy.[31] 
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 it has been reported that transition of Aβ1–40 from α-helical structure cytotoxic β-sheet structure 
occurs due to the variation in the solvent polarity; additionally, change in pH and salt 
concentration cause transition of oligomers into protofibrils, followed by amyloid fibril 
formation [32]. There is evidence that amyloid fibrils of Aβ1–40 initiate amyloid formation in 
different globular proteins and metabolites, converting native structures into β-sheet rich 
assemblies [33]. Moreover, contacts between Aβ peptide’s cross β structure and the native folds 
of proteins mediated through H-bonds and hydrophobic interactions, resulting in onset of 
amyloid cross-seeding [33]. It has also been reported that the mixture of monomeric 13C-labeled 
Aβ1–40 and unlabeled Aβ1–42 form mixed oligomers with largely random distribution of Aβ1–40 
and Aβ1–42 [34]. A combination of nuclear magnetic resonance, thioflavin-T fluorescence, 
transmission electron microscopy and dynamic light scattering was applied to characterize the 
aggregation kinetics of Aβ1-40 peptide where it was reported that at 37 °C soluble Aβ1-40 remains 
intrinsically disordered and mostly in monomeric form despite evidence of the presence of 
dimers and/or other small oligomers.[35] 
 
Okada et al. [36] reported that the fibril formation of Aβ1–40 on monosialoganglioside 
GM1 clusters are more cytotoxic than those formed in aqueous solution and the structure of this 
highly toxic fibril contains in register parallel and two-residue-shifted antiparallel β-sheet 
however less toxic fibril contains only in register parallel β-sheet. The study of aggregation Aβ1–
40 was performed by using NMR spectroscopy which showed that the aggregation was initiated 




The brains of cognitively normal individuals may contain large amounts of Aβ peptides 
[38]. During the onset and progression of AD, N-terminally truncated hypertoxic Aβ species 
bearing the pyroglutamate modification accumulates and reaches 40-50% of total Aβ load [39-
46]. It has been reported that pyroglutamate-Aβ (pE-Aβ) has a higher proclivity for aggregation 
than the unmodified full-length Aβ by a seeding mechanism and is resistant to degradation, 
allowing these peptides to persist in biological fluids and tissues [38]. The formation of pE-Aβ is 
a multi-step process (Figure 1.2). Naturally occurring enzymatic removal of the first two amino 
acid residues of Aβ and pyroglutamylation of Glu3 produces Aβ species of elevated toxicity, i.e., 
pEAβ 3-40 [47,48].  
pEAβ3-40 is more hydrophobic than Aβ1-40 due to the loss of negative charges from the 
Asp1 and Glu3 residues, and formation of the lactam ring in the pE residue. AβpE3-40 aggregates 
earlier and acts as a seed for Aβ aggregation by self-aggregation and co-aggregation with Aβ1-
40/42, playing a critical role in the early stage of amyloid formation in AD displaying an enhanced 





Figure 1. 2: (Left) N- truncations can generate Aβ peptides with exposed glutamate at position 3 
or 1. Aβ peptide sequence is shown for the first 20 residues. Glutaminyl cyclase (QC) converts 
exposed glutamate residues to the more hydrophobic and aminopeptidase resistant pyroglutamate 
residue. (Right) Schematic representation of pE-Aβ formation and the resulting biophysical and 
biochemical effects. Multiple potential mechanisms for Aβ N-terminal truncation have been 
proposed—the exact mechanism could involve one or more of these pathways or a yet 
unidentified cleavage process. Source: Gunn et al. [46]. 
Circular dichroism (CD) data showed that in trifluoroethanol (TFE)/water (1:5, v/v) 
mixture, pEAβ3-40 displayed an increased β-sheet propensity while Aβ1-40 formed α-helical 
structure [50]. In addition, thioflavin-T (ThT) fluorescence assay identified typical sigmoidal 
aggregation kinetics for pEAβ3-40 whereas Aβ1-40  showed no ThT signal, indicating resistance to 
fibrillogenesis. Transmission electron microscopy (TEM) identified β-sheet-rich fibrils for 
pEAβ3-40. Finally, NMR data showed significant structural differences in the N-terminal regions 
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of Aβ1-40 and pEAβ3-40 , which decreases monomer stability of the latter peptide and promotes 
cross β-sheet fibril formation.  
By performing the analysis of senile plaques, the aggregated individual pEAβ and 
unmodified Aβ as well as their heterogeneous intermixed were found.[51] further study had 
shown that the immunohistochemical examination of postmortem brains of different ages 
revealed that plaques in brains of younger subjects contained mostly pEAβ, and the ratio 
Aβ/pEAβ increased with age, suggesting that deposition of pEAβ leads that of the Aβ.[51] The 
pEAβ load in postmortem human brains correlated with hyperphosphorylated tau protein and 
predicted AD better than unmodified Aβ.[52] Harigaya et al. had shown that even though the 
pEAβ3-42 was a major component of senile plaques in AD brains (25% of total Aβ1–42),  
pEAβ3-40 formed deposits mainly in the cerebral vasculature.[52] 
Wulff et al. [53] demonstrated that AβpE has higher susceptibility to mechanical stress 
and fragmentation of the fibrils. This report has been challenged by other studies, arguing that 
pE-Aβ assemblies have similar content of β -sheet structure, are more resistant to fibrillogenesis 
[55-57], and exert cytotoxic effect similar to unmodified Aβ [54,56,57]. 
The structure, aggregation and neurotoxicity of a peptide affected strongly by N-terminal 
pyroglutamylation. In murine brains, pEAβ3-40 inhibited hippocampal long-term potentiation 
[58]and utilized stronger cytotoxic effect on cultured rat hippocampal neurons than Aβ1-40, Aβ1-
42, and even pEAβ3-42.[59] The molecular basis of the greater toxicity of pEAβ remains obscure. 
Whereas in some studies have shown that the aggregation into β-sheet-rich assemblies for 
pEAβ3-40 more readily than Aβ1-40,[47,48,50] others have found similar toxicities[60] and 
structural features of unmodified and pyroglutamylated Aβ peptides in fibrillar or oligomeric 
states[61] and lengthier aggregation of pEAβ,[62] leaving the issue unclear.  
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The structural and aggregation properties of unmodified Aβ and pE-Aβ are important for 
their respective cytotoxic effects. However, these biophysical characteristics have not been 
firmly established. Therefore, the main focus of this project is on comparative characterization of 
aggregation and accompanying structural changes of Aβ1-40 and pEAβ3-40 separately and in 
combination.  
In addition, smaller fragments of Aβ have studied in this project in order to identify the 
specific regions of the peptide initiating -helix to β-sheet transition, aggregation, and fibril 
formation. Several studies performed experiments use peptide fragments related or unrelated to 
A sequence to inhibit A aggregation and hinder A-induced cytotoxicity. [63-75] The peptide 
fragment’s inhibitory effect on A aggregation and toxicity originates from their capacities to 
intercalate into A assemblies and prohibit the formation of toxic oligomers, which may or may 
not be associated with their own self-aggregation propensities. Therefore, a mutated peptide, 
KLVFWAK, imitating the A16-22 (KLVFFAE) which had minimal self-aggregation propensity 
but favorably interrelated with oligomeric and fibrillar structures of A On the other hand, 
the natural sequence of A16-22 has been known as a fibrillogenic segment that forms antiparallel 
-sheet aggregates stabilized by ionic interactions between terminal side chains and nonpolar 
interactions between internal hydrophobic residues. [77,78] Cheng et al. [69] had shown that 
A16-22, among several A segments integrated in a full-length peptide, inhibited A1-40 
aggregation and cytotoxicity. These effects were inferred in terms of binding of the fragment 
peptide to A oligomers and inhibition of fibril nucleation. Simultaneously, the same A16-22 
peptide, as well as the hydrophobic C-terminal stretch from Lys28 onward, were established to be 
the most fibrillogenic regions in the perspective of several A species containing 38 to 43 amino 
acids. [84] Coherent with these outcomes, the peptides A28-42 and A29-42 exhibited fast 
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aggregation and -sheet fibril formation propensities contrasting some other C-terminal A 
peptide fragments. [83] Furthermore, midst twelve C-terminal A1-42 fragments A28-42 exerted 
extreme toxic effect on cultured PC-12 cells [83] and insinuated correlation between 
amyloidogenicity and toxic effects of the peptides. Additionally, by interfering with formation of 
toxic oligomers two C-terminal fragments, A31-42 and A39-42, were capable to rescue neuronal 
cells from A1-42 cytotoxicity [79].  
Therefore, by direct interaction with full-length peptide A fragments of A appear to 
affect the aggregation and toxicity of full-length one. Reports on the aspects of binding of 
fragments to the full-length peptide exposed various modes of interaction. The study of A 
fragment A33-37 (GLMVG) shown that it binds with C- terminus of A1-42, probably the 
homologous sequence, and suppress its aggregation, neuronal membrane damage and 
synaptotoxicity [70]. Surprisingly, another short C-terminal fragment, A39-42, favorably 
interrelated with the N-terminus of A1-42 in oligomeric form [80-82]. The aforementioned 
mutated peptide, KLVFWAK, also interacted in a non-homologous manner with the C-terminus 
of A aggregates [76].  
These outcomes suggest that A aggregation can be essentially modulated by A-derived 
peptide fragments. Nevertheless, a comprehensive understanding of the variant effects of A 
segments along the whole A1-42 sequence has not been attained. This work aimed at systematic 
studies on 10 amino acid residue long overlapping fragments of A1-42 to understand their 
intrinsic -sheet formation and fibrillogenesis properties and their effects on same properties of 
the parent peptide. Here structural and aggregation properties of the parent Aβ1-42 peptide and 
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seven overlapping peptide fragments have been studied, i. e. Aβ1-10 (P1), Aβ6-15 (P2), Aβ11-20 (P3), 
Aβ16-25 (P4), Aβ21-30 (P5), Aβ26-36 (P6), and Aβ31-42 (P7). 
1.3 Protein Structure 
 
The protein structure is the three-dimensional arrangement of atoms in the amino acid 
chain molecule. Proteins are polymers, which are formed by amino acid sequences. A single 
amino acid monomer can also be referred to as a residue implying a repeating unit of the 
polymer. Proteins are formed by amino acids that undergo condensation reactions, where the 
amino acids lose one water molecule each time they react and are connected to each other 
through peptide bonds. By convention, chains of less than 30 amino acids are usually identified 
as peptides, not proteins. 
In order to perform its biological functions, proteins are driven by a series of non-
covalent interactions (such as hydrogen bonds, ionic interactions, van der Waals forces, and 
hydrophobic packaging) to fold into one or more specific spatial conformations. To understand 
the functions of proteins at the molecular level, it is often necessary to determine their three-
dimensional structure. This is the subject of structural biology science, which uses techniques 
such as Fourier Transform Infrared (FTIR) spectroscopy, Circular dichroism (CD), X-ray 
crystallography, nuclear magnetic resonance spectroscopy, cryo-electron microscopy (cryoEM), 
and dual polarization interferometry to define the structure of proteins.  
The size of the protein structure varies from dozens to thousands of amino acids. 
According to their physical size, proteins are classified as nanoparticles, between 1 and 100 nm. 
Very large protein complexes can be formed from protein subunits. 
The primary structure of a protein indicates to the sequence of amino acids in the 
polypeptide chain. The primary structure is held together by peptide bonds formed during protein 
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biosynthesis. According to the nature of the free groups at both ends, the ends of the polypeptide 
chain are called carboxyl terminus (C-terminus) and the amino terminus (N-terminus) 
respectively. The residue count always starts from the N-terminal end (NH2- group), which is the 
end where the amino group does not participate in the peptide bond. The primary structure of a 
protein is determined by the gene for the protein. A specific sequence of nucleotides in DNA is 
transcribed into mRNA, which the ribosome reads in a process called translation. The sequence 
of the protein is unique to the protein and defines the structure and function of the protein. The 
sequence of the protein can be determined by methods such as tandem mass spectrometry. 
However, it is usually read directly from the gene sequence using the genetic code. It is strictly 
recommended to use the term "amino acid residues" when talking about proteins, because when a 
peptide bond is formed, a water molecule is lost, so proteins are composed of amino acid 
residues. Post-translational modifications such as phosphorylation and glycosylation are usually 
considered part of the primary structure and cannot be read in genes. 
The next level of protein structure, the secondary structure, indicates to the partially 
folded structure formed in the polypeptide due to the interaction between the backbone atoms. 
(The main chain refers only to the polypeptide chain other than the R group; the secondary 
structure does not include the R group atoms.) The most common types of secondary structure 
are α- helices and β-sheets. Both structures maintain their shape through hydrogen bonds, which 
are formed between the carbonyl C=O of one amino acid and the amide NH of the other amino 
acid. 
In the α-helix, the carbonyl group (C = O) of the amino acid forms a hydrogen bond with 
the amino group H (N-H) of the 4 amino acids in the chain. This bonding pattern draws the 
polypeptide chain into a helical structure that resembles a curled ribbon, each turn of the spiral 
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containing 3.6 amino acids. acid. The R groups of amino acids protrude from the alpha helix, 
where they can interact freely. 
In β-sheets, two or more segments of the polypeptide chain are arranged next to each 
other to form a sheet-like structure, which is held together by hydrogen bonds. A hydrogen bond 
is formed between the carbonyl group and the amino group of the skeleton, and the R group 
extends above and below the plane of the sheet. The strands of the folded sheet β can be parallel, 
pointing in the same direction (meaning that its N- and C-termini coincide), or anti-parallel, 
pointing in the opposite direction (meaning that the N-terminus of one strand is positioned next 
to the C-terminus of the other). Some amino acids are more or less likely to appear in alpha 
helices or beta sheets. For example, the amino acid proline is sometimes called a "helix breaker" 
because its unusual R group (attached to an amino group to form a ring) creates a bend in the 
chain and is incompatible with helix formation. Proline is generally found in curved, 
unstructured regions between secondary structures. Similarly, amino acids with a large ring 
structure in the R group, such as tryptophan, tyrosine, and phenylalanine, are often found in β 
sheets, which may be because the β sheet structure provides sufficient side chains. 
The general three-dimensional structure of a polypeptide is called the tertiary structure. 
The tertiary structure is mainly due to the interaction between the R groups of the amino acids 
that make up the protein. The R group interactions that contribute to the tertiary structure include 
hydrogen bonds, ionic bonds, dipole-dipole interactions, and London dispersion forces - 
basically the full range of non-covalent bonds. For example, R groups with the same charge repel 
each other, while groups with opposite charges can form ionic bonds. Similarly, polar R groups 
can form hydrogen bonds and other dipole-dipole interactions. Also important for tertiary 
structure is hydrophobic interaction, in which amino acids with nonpolar hydrophobic R groups 
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are brought together inside the protein, while hydrophilic amino acids are left outside to interact 
with surrounding water molecules. Ultimately, there is a special type of covalent bond that 
promotes the tertiary structure: disulfide bonds. Disulfide bonds, the covalent bonds between the 
side chains of sulfur-containing cysteine, are much stronger than other types of bonds that 
contribute to the tertiary structure. They act as molecular "safety pins", making the various parts 
of the polypeptide firmly connected to each other 
Many proteins are composed of a single polypeptide chain and only have a tertiary 
structure. However, some proteins are made up of multiple polypeptide chains, also called 
subunits. When these subunits are grouped together, they give the protein a quaternary structure.  
 An example of a protein with a quaternary structure: hemoglobin. Hemoglobin carries 
oxygen in the blood and is composed of four subunits, two for each type α and β. Another 
example is DNA polymerase, an enzyme that synthesizes new DNA strands, composed of ten 
subunits.  
 Generally speaking, the same types of interactions that contribute to the formation of 
tertiary structures (mainly weak interactions, such as hydrogen bonds and London scattering 
forces) also combine subunits to form quaternary structures. 
1.4 Protein-Protein Interaction 
Protein-protein interaction (PPI) deals with a wide range of biological processes, 
including cell-cell interactions and developmental and metabolic control. Protein-protein 
interaction is becoming one of the main objectives of systems biology. Non-covalent contact 
between the side chains of the residues is the basis for protein folding, protein assembly, and 
PPI. These contacts induce various interactions and associations between proteins. According to 
its comparative structural and functional characteristics, PPI can be classified in a variety of 
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ways. Based on their interaction surface, they can be homologous or heterogeneous; from their 
stability, they may or may not be obligated; in terms of their persistence, they can be temporary 
or permanent. The given PPI can be a combination of these three specific pairs. Transient 
interactions will form signal pathways, while permanent interactions will form stable protein 
complexes. 
Generally, proteins rarely act as isolated species when they perform their functions in 
vivo. It has been found that more than 80% of proteins do not act alone but in the form of 
complexes. An extensive analysis of validated proteins showed that proteins involved in the 
same cellular process were repeatedly found to interact with each other. The study of PPI is also 
important for inferring the function of proteins in cells. The function of unknown proteins can be 
predicted from the evidence of their interaction with the protein, and the function of the protein 
has been revealed. The detailed study of PPI has accelerated the modeling of functional 
pathways to illustrate the molecular mechanisms of cellular processes. Characterizing the 
interactions of proteins in a given proteome is very useful for revealing the biochemistry of cells. 
There are many ways to determine the result of two or more proteins interacting with a defined 
functional target. Phizicky and Fields have outlined the important characteristics of PPI. [151] 
PPIs can change the kinetic properties of enzymes; as a general mechanism to allow the substrate 
to pass through; it constructs new binding sites for small effector molecules; Inactivate or inhibit 
proteins; Change the specificity of the protein to its substrate through interaction with different 
binding partners; Play a regulatory role at the upstream or downstream level. 
Revealing information about protein-protein interaction can help determine drug targets. 
Studies have shown that proteins with a large number of interactions (centers) can include 
families of enzymes, transcription factors, and inherently disordered proteins [152,153]. 
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However, the PPI involves more heterogeneous processes, and its regulatory scope is greater. To 
understand its importance in cells more precisely, it is necessary to identify various interactions 
and determine the consequences of the interactions. 
1.5 Protein Solubility 
Protein solubility is a thermodynamic parameter defined as the concentration of protein in a 
saturated solution that is in equilibrium with a solid phase, either crystalline or amorphous, under 
a given set of conditions. Depending on pH conditions, proteins can be positively charged 
(cations) or negatively charged (anions). When the positive and negative charges on the protein 
are equal, the net charge is zero. The characteristic pH value of the solution when the net charge 
of the protein is zero (the positive and negative charges are equal) is defined as the isoelectric 
point (pI). Under conditions of pH below its isoelectric point, the protein will carry a net positive 
charge and will behave as a cation. At a pH above its isoelectric point, the protein will have a net 
negative charge. The isoelectric point of a protein is an important characteristic, because at this 
point the solubility of the protein is lowest and therefore unstable. It should be noted that 
proteins are soluble below and above the isoelectric point (pI). 
Salt bridges are ionic bonds between positively charged and negatively charged amino acid side 
chains. An example is the attraction between the -COO- ion of glutamic acid and the NH+3 ion of 
lysine. Increasing the pH by adding a base will convert NH+3 ions into neutral NH2 groups. 
Lowering the pH by adding acid will convert –COO- ions into neutral COOH groups. In each 
case, the ionic attraction disappears, and the shape of the protein unfolds. Additionally, salt 
concentration (ionic strength) is also very important for protein solubility. At low salt 
concentrations protein solubility increases and at high salt concentration protein solubility 
decreases. 
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1.6 Basic Aspects in Protein Stability 
The influence of salt on the structure and function of non-halophilic proteins has been 
well resolved. The presence of high salt content in the protein solution will have the following 
effects: interference of the local water structure around the protein; reduction of the tendency of 
intermolecular hydrogen bonds to affect the solubility, binding, stability and crystallization of the 
protein; Increase the surface tension of water, striping off the essential water layer from the 
protein surface and increase the hydrophobic interaction, which leads to the aggregation and 
precipitation of proteins. However, a high concentration of salt can adversely affect the structure 
of proteins and their subsequent function. 
 
Protein denaturation refers to the loss of biological activity caused by changes in protein 
structure caused by physical or chemical factors such as pH, temperature, salt, detergents, 
organic solvents, or chaotropic agents. Secondary, tertiary, or quaternary structure is greatly 
affected by denaturation. Some important mechanisms of protein denaturation are 
(http://class.fst.ohio-state.edu/FST822/lectures/Denat.htm): 
• High temperature weakens the inherent bonds in proteins. The additional heating will 
destroy the hydrogen bonds in the protein and establish new hydrogen bonds with the 
surrounding water molecules, thus destroying the helical structure. 
• Water miscible solvent (less polar than water) reduce the dielectric constant of the 
system, thus strengthening electrostatic interactions between molecules. The protein 
unfolds to a great extent, exposing the hydrophobic group to the solvent, leading to 
aggregation and precipitation. 
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• Proteins are usually more soluble in dilute salt solutions because the salts in their ionic 
forms associate with opposite charges within the protein moiety, leading to increased 
hydration of the surface. However, at very high salt concentration, the increased surface 
tension of water generates a competition between protein and salt ions for hydration. 
Salts strip off the essential layer of water molecules from the protein surface eventually 
denaturing the protein. 
• Protein denaturation caused by urea can occur through direct or indirect mechanisms. 
Urea can directly interact with the protein through the hydrogen bond with the polarized 
region of the protein surface, weakening the intermolecular bond and structure of the 
protein. Guanidine hydrochloride (GdmCl) has a similar mechanism, but it is a more 
effective denaturant than urea. In an indirect mechanism, urea can change the structure of 













CHAPTER 2: RESEARCH STRATEGY 
 
2.1 Fourier Transform Infrared (FTIR) Spectroscopy 
 
For identification and analysis of structure of chemical compound, mid-infrared (IR) 
spectroscopy is a well-establish technique. The excitation of vibrational modes of the molecules 
in the sample and the association with other chemical bonds and functional groups in the 
molecules are represented the various peaks in the IR spectrum. Therefore, the infrared spectrum 
of a compound is one of its most characteristic physical properties and can be regarded as its 
"fingerprint". 
The molecular absorption of electromagnetic radiation in the infrared region of the spectrum 
(Figure 2.1) promotes the transition between the rotational energy level and the vibratory energy 
level of the electronic energy state of the ground (lower). This is in contrast to the more energetic 
absorption of visible and ultraviolet radiation, which causes the transition between the energy 
levels of vibration and rotation of different electronic energy state. Infrared spectroscopy mainly 
involves molecular vibrations, because the transition between individual rotational states can 




Figure 2. 1: The regions of the electromagnetic spectrum. 
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A nonlinear molecule composed of N atoms is said to have 3N degrees of freedom, because if 
the position of each atom is described by three coordinates (for example, x, y, z in the Cartesian 
coordinate system), then the position, shape and the orientation of the molecules in three-
dimensional space will be completely defined. Since a total of three coordinates are required to 
describe the translation of the molecule (for example, along the x, y, and z axes), the molecule 
has three translational degrees of freedom. The other three degrees of freedom represent the 
rotation of the molecule around three axes. The remaining 3N-6 degrees of freedom correspond 
to vibratory motion, and the molecule is said to have normal 3N-6 modes of vibration. These 
vibration modes can be described by bond stretching and various types of bending vibrations (see 
Figure 2X). In the case of linear molecules, there are only two rotational degrees of freedom, 
because rotation around the bond axis is impossible. Therefore, linear molecules have a normal 













Figure 2. 2: Visualization of all different molecular vibrations, arrows indicate movements 
resulting from repulsion caused by electronegativity. Specific molecules move on a specific 
frequency, which absorbs energy when it equals light frequencies (source: USDA) 
 
Therefore, a simple diatomic molecule A-B has (3 x 2) − 5 = 1 vibration mode, which 
corresponds to stretching with the A-B bond. This stretching vibration is similar to the vibration 
of two objects connected by a spring. Hence, in the first approximation, the harmonic oscillator 
model can be used to describe this vibration, and then the restoring force (F) on the bond is given 
by Hooke's law: 
                                 F =  −kx … … … … … … … … … … … … . . … … … … … … … … … . . … … … … . . (1) 
where k is the force constant of the bond, and x is the displacement. 
In this approximation, the vibrational frequency  ν is given by: 
 








… … … … … … … … … … … … … … … … … … … . . … … … … … (2) 
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with μ is the reduced mass of the system,  
 
                                 μ =  
mA. mB 
mA + mB
… … … … … … … … . . … … … … … … … … … … … … … … . . … … (3) 
 
where mA and mB are the individual atomic masses of A and B.  
The unit of frequency (ν) is reciprocal seconds (sec-l). However, by convention, band positions in 
infrared spectra are given in wavenumbers (𝑣), expressed in units of reciprocal centimeters  
(cm-l), and are often termed "band frequencies." In older literature, band positions are often 
reported in units of wavelength (𝜆), The relation between these units is given by equations (4) 
and (5): 
                                    v =  
1
𝜆
… … … … … … … … … … … … … … … … … … … … … … … … . . … . . . (4) 
                                    ν =  
𝑐
𝜆
… … … … … … … … … … … . . . . … … … … … … … … … … … . . … … … (5) 
 
where c = velocity of light.  
The situation for a many-atom molecule is more complicated than equation (2) because the 
measured vibrational frequencies do in general, correspond to mixtures of different vibrations 
rather than pure vibrations. Additionally, electrical effects, steric effects, the nature, size and 
electronegativity of neighboring atoms, phase changes and hydrogen bonding may all cause 
shifts in frequency. Instead, the above process is the basis of the group frequency concept. 
According to this concept, it is expected to show a characteristic absorption frequency that can 
establish from the IR spectrum that various functional groups are present in the compound.  
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The quantum mechanical treatment of molecular vibration leads to the modification of the 
harmonic oscillator model. Although the above treatment of Hooke's law shows the continuity of 
the vibrational states, the molecular vibrational energy levels are quantized: 
                                   E = (n +
1
2
) hν … … … … … … … … . … … … … … … … … … … … … … … … (6) 
where h is Planck's constant, n is the vibrational quantum number, and ν is 
the fundamental vibrational frequency.  
Therefore, only when the frequency is consistent with the frequency of one of the basic vibration 
modes of the molecule, the molecule will absorb infrared radiation of a specific frequency. It can 
be seen from equation (6) that in the harmonic oscillator approximation, quantum mechanical 
processing predicts equidistant vibration energy levels. It also predicts that at room temperature, 
only the transition from the ground state vibrational energy level (n = 0) to the first excited 
vibrational energy level (n = 1) will occur. However, through experiments, harmonic bands are 
observed, corresponding to the transition to higher vibration levels, and their frequencies are 
slightly lower than integer multiples of the fundamental vibration frequency. These effects are 
due to the anharmonic nature of molecular vibrations. Anharmonicity also produces a combining 
band, which represents the simultaneous excitation of two fundamental vibration modes. The 
harmonic and combined bands, which are "forbidden" bands, are about an order of magnitude 
weaker than the basic mode. Near infrared (NIR) spectroscopy involves the study of such bands 
in the near infrared region of the spectrum (12800-4000 cm-1). 
Lastly, it is significant to note that all molecular vibrations will not produce infrared absorption 
bands. Only when the excitation of this vibration causes the dipole moment of the molecule to 
change, the fundamental vibration mode will be "active IR". Therefore, N2, O2, and other 
homonuclear diatoms will not produce IR absorption bands. Correspondingly, the symmetric 
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stretching of linear X-Z-X molecules (see Figure 2) (like CO2) will not be an active infrared 
vibration. Additionally, the symmetry of the molecule influences the number of absorption bands 
that will appear in its infrared spectrum. For example, due to molecular symmetry, when two 
vibrations have the same energy (degenerate vibration), they will produce a single IR absorption 
band. The expectation of the number of bands observed in the infrared spectrum of molecules 
based on molecular structure and symmetry is the domain of group theory. 
 
FTIR is widely used in biophysical/structural characterization of biomolecules. Specific spatial 
arrangements of atoms in defined secondary structural geometries, which are stabilized by 
hydrogen bonding of certain strength that is inversely proportional to covalent bond strength, 
produce absorption bands at characteristic frequencies. This allows one to evaluate the 
molecule’s overall secondary structure by analysis of the spectrum. Proteins generate a number 
of “amide” bands, of which the amide I band, a composite vibrational mode involving mostly the 
C=O stretching vibration, is the most conformation-sensitive feature. For example, 𝛼-helix and 
𝛽-sheet structures generate absorption bands around 1655 cm-1 and 1630 cm-1 [85], so an 𝛼 / 𝛽 
protein will produce an amide I band with two major components at these wavenumbers, and its 
structure can be determined from the relative weights of these components, with correction for 
respective extinction coefficients. FTIR spectroscopy, along with some other spectroscopic 
methods such as circular dichroism, are considered “low resolution” techniques. These 
techniques provide the global structure of proteins bot not the precise 3-dimensional structure at 
an atomic level, unlike some other methods such as X-ray crystallography and NMR. The 
advantage of these “low resolution” methods is their accessibility, which allows collection of 
valuable structural information in a short time (~1 hour), using tiny amounts (~0.01-0.1 mg) of 
sample. In addition, proteins are studied in their natural milieu, i.e. an aqueous environment, 
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rather than crystals or organic solvents. FTIR is practically free of light scattering problems 
because of the long wavelengths, and is not restricted by the protein size, like NMR [86]. In 
addition, membrane proteins, which are very difficult to crystallize, are being easily studied by 
FTIR, using either lipid vesicle-reconstituted proteins or by attenuated total reflection FTIR on 
proteins embedded in supported membranes. Sine FTIR measurements are conducted in D2O-
based buffers (H2O absorbs in the amide I region), solvent exposure of the protein interior upon 
structural changes or unfolding results in amide hydrogen exchange (NH to ND), which 
downshifts the amide II band by ~100 cm-1, from 1540 cm-1 to 1440 cm-1. This allows evaluation 
of the tertiary structural changes in proteins by following the kinetics of amide hydrogen 
exchange. 
 
2.2 Circular Dichroism (CD) Spectroscopy 
 
CD is electronic spectroscopy based on chirality of molecules. Since amino acids contain a 𝐶𝛼  
chiral atom (except for glycine), CD is widely used in structural studies of proteins [65-67]. CD 
spectroscopy is used extensively to study chiral molecules of all types and sizes, but it is in the 
study of large biological molecules where it finds its most important applications. 
A chromophore that is asymmetric in nature or a symmetrical chromophore in an asymmetric 
environment will interact differently with left and right circularly polarized light, resulting in two 
related phenomena. Since the refractive index of right circularly polarized light and left 
circularly polarized light are different, circularly polarized light will pass through the optically 
active medium at different speeds, which is called optical rotation or circular birefringence. The 
change in optical rotation as a function of wavelength is called optical rotation dispersion 
(ORD). Due to the different extinction coefficients of the two polarized light called circular 
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dichroism (CD), left and right circularly polarized light will also be absorbed to different degrees 
at certain wavelengths. Optical rotating scattering allows chiral molecules to rotate the plane of 
polarized light. The ORD spectrum is dispersive (called the single band’s cotton effect), while 
the circular dichroic spectrum is absorbent. These two phenomena are related to the so-called 
König -Kramers transformation. 
It can be exhibited that if right- and left-handed circularly polarized light is absorbed to different 
degrees at any wavelength, there will be a difference in refractive index at almost all 
wavelengths. ORD scattering is also the reason why CD is a more sensitive analytical technique. 
Unlike the dispersive ORD phenomenon, circular dichroism can only occur in the normal 
absorption band and therefore requires inherent asymmetric chromophores (uncommon) or 
symmetric chromophores in asymmetric environments. 
Electromagnetic radiation consists of an electric (E) and magnetic (B) field that oscillate 
perpendicular to one another and to the propagating direction, a transverse wave. While linearly 
polarized light occurs when the electric field vector oscillates only in one plane, circularly 
polarized light occurs when the direction of the electric field vector rotates about its propagation 
direction while the vector retains constant magnitude. At a single point in space, the circularly 
polarized vector will trace out a circle over one period of the wave frequency, hence the name. 
The two diagrams below (Figure 2.3) show the electric field vectors of linearly and circularly 
polarized light, at one moment of time, for a range of positions; the plot of the circularly 
polarized electric vector forms a helix along the direction of propagation (k). For left circularly 
polarized light (LCP) with propagation towards the observer, the electric vector rotates 
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counterclockwise. For right circularly polarized light (RCP), the electric vector rotates 
clockwise. 
 
Figure 2. 3: Linearly (left) and circularly (right) polarized light. 
The different absorption of radiation polarized in two directions as a function of frequency is 
called dichroism. When applied to plane polarized light, this is called linear dichroism; for 
circularly polarized light, circular dichroism. The linearly polarized light is the result of two of 
equal amplitude opposite circular polarizations. After passing the optically active sample, the 
circularly polarized light will change in two ways. These two components are still circularly 
polarized, but the size of the E component that rotates in the opposite direction will no longer be 
the same, because the molar extinction coefficients of the left polarized light and the right 
polarized light are not equal. The E-vector direction no longer draws a circle but an ellipse 
(actually an elliptical spiral, if not limited to projection) due to the difference in refractive index, 
the major axis of the ellipse will also rotate. 
Generally, ellipticity is a unit of circular dichroism, defined as the tangent of the ratio of the 
minor axis to the major axis of the ellipse axis. An axial ratio of 1:100 will result in an ellipticity 
of 0.57 degrees. Modern CD instruments have millisecond accuracy. Although CD is now 
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measured as the difference in absorbance of left and right circularly polarized light as a function 
of wavelength, the unit ellipticity still exists. Each type follows Lambert Beer's law, so the 
difference in extinction coefficient (left and right) at a given wavelength is equal to the 
difference in absorbance divided by the product of optical path length and concentration. 
CD instruments (known as spectropolarimeters) measure the difference in absorbance between 
the L and R circularly polarized components (∆𝐴 = 𝐴𝐿 − 𝐴𝑅  = (𝜖𝐿 − 𝜖𝑅)𝑙𝑐 ), where the 
subscripts R and L signify right and left polarization, l is the optical pathlength (thickness) of the 
sample, and c the solute concentration. Differential absorption of right- and left- polarized lights 
results in conversion of a plane-polarized light into elliptically polarized light (note that the 
plane-polarized light can be presented as a sum of right- and left-polarized components of equal 
amplitudes). The ellipticity (𝜃), is simply the ratio of the minor and major semiaxes of the ellipse 
(Figure 2.4). 







For small 𝜃, tan 𝜃 = 𝜃 
It can be shown that, 𝜃 (𝑑𝑒𝑔) = 180 × ln 10 × 
∆𝐴
4𝜋
= 32.98 ∆𝐴 





Figure 2. 4: Origin of the CD effect. (A) The left (L) and right (R) circularly polarized 
components of plane polarized radiation: (I) the two components have the same amplitude and 
when combined generate plane polarized radiation; (II) the components are of different 
magnitude and the resultant (dashed line) is elliptically polarized. (B) The relationship between 
absorption and CD spectra. Band 1 has a positive CD spectrum with L absorbed more than R; 
band 2 has a negative CD spectrum with R absorbed more than L; band 3 is due to an achiral 
chromophore. (C) Elliptical polarized light (violet) is composed of unequal contributions of right 
(blue) and left (red) circular polarized light. 
n-π∗ transitions involve moving an electron from a nonbonding electron pair to a antibonding π∗ 
orbital. They tend to have molar absorbtivities less than 2000 and undergo a blue shift with 
solvent interactions (a shift to higher energy and shorter wavelengths). This is because the lone 
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pair interacts with the solvent, especially a polar one, such that the solvent aligns itself with the 
ground state. When the excited state emerges, the solvent molecules do not have time to 
rearrange in order to stabilize the excited state. This causes a lowering of energy of the ground 
state and not the excited state. Because of this, the energy of the transition increases, hence the 
"blue shift”. The n-π∗ transition in peptides occurs at 210-225 nm (𝜖  100 M-1 cm-1). The strong 
band responsible for the absorbance of most peptide bonds is the 𝜋-𝜋* transition. The π-π∗ 
transitions involve moving an electron from a bonding ππ orbital to an antibonding π∗π∗ orbital. 
They tend to have molar absorptivities on the order of 10,000 and undergo a red shift with 
solvent interactions (a shift to lower energy and longer wavelengths). This could either be due to 
a raising of the ground state energy or lowering of the excited state energy. If the excited state is 
polar, then it will be solvent stabilized, thus lowering its energy and the energy of the transition. 
Using CD, these different transitions are more distinctly evident. The two types of 𝜋-𝜋* 
transitions occur around 210 and 190 nm (𝜖  7,000 M-1 cm-1). 
A CD spectrum of a protein is usually measured in the 180 nm to 350 nm ultraviolet (UV) 
region. The far-UV signal between 180 and 250 nm is sensitive to protein’s secondary structure. 
The 𝛼-helical structure produces two minima around 208 and 222 nm and a maximum around 
192-195 nm, and 𝛽-sheet structure generates a minimum at 216 nm and a maximum around 195 
nm [68, 69]. Unordered proteins produce a weak maximum around 220 nm and a deep minimum 
around 195-200 nm [68, 69].  The CD signal in the near-UV region (~ 280 nm) is generated by 
the side chains of aromatic amino acids (Trp, Tyr, Phe) that “borrow” dichroic properties from 
the nearby backbone 𝐶𝛼 atoms. It is often used to characterize the protein’s tertiary structure, the 
signal increases with increasing compactness of the protein’s fold.  CD thus can be used to 
observe how the secondary and tertiary structures of a protein or peptide change with 
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environmental conditions (pH, temperature, salt concentration) or upon interaction with other 
molecules. Structural, kinetic and thermodynamic information about macromolecules can be 
derived from circular dichroism spectroscopy. 
 
2.3 Fluorescence Spectroscopy (FS) 
 
 FS is electronic spectroscopy that is based on light absorption and emission by certain 
molecules. The incident light, usually in the UV or visible regions, is absorbed by electronic 
transition from the ground state to the higher energy excited state. Both ground and excited states 
have many vibrational energy levels that are spaced more closely compared to the energy 
difference between the ground and excited levels. The excited electron loses some of its energy 
by adopting the lowest vibrational level. Before returning, the electron also loses some of its 
energy by various mechanisms, mostly by “solvent relaxation”, i.e. reorienting the polar solvent 
molecules, such as H2O. Then, within about 10 ns, the electron returns to the ground state, 
emitting light. Through the aforementioned mechanisms, the emitted light carries less energy and 
thereby the emission occurs at longer wavelengths than the excitation (Stokes shift) [92]. As 
molecules may drop down into any of several vibrational levels in the ground state, the emitted 
photons will have different energies, and thus wavelengths, producing an emission band with 
nearly Gaussian distribution of intensities.  
Best known fluorescent organic molecules are the aromatic rings. Three out of twenty 
amino acids found in proteins, i.e. tryptophan (Trp), tyrosine (Tyr), and phenylalanine (Phe), 
have such rings and therefore are intrinsically fluorescent. The location of the emission band 
relative to the excitation along the wavelength axis indicates how strong the solvent relaxation is. 
Stronger solvent relaxation occurs for proteins with more open, solvent accessible tertiary 
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structure, which is manifested by a higher emission wavelength (red shift). Proteins with more 
compact tertiary structure display emission at shorter wavelength (blue shift), closer to the 
excitation wavelength. Thus, FS is sensitive to protein’s tertiary structure, and together with CD 
is used for comprehensive structural characterization of proteins. 
2.4 Peptide Preparation 
 
2.4.1 Preparation for Structure and Aggregation of Aβ1-40 and Pyroglutamylated pEAβ3-40 
Separately and Combined. 
 
Synthetic Aβ1–40 and pEAβ3–40 peptides were purchased from Innovagen (Lund, Sweden). 
Recombinantly expressed, uniformly 13Clabeled Aβ1–40 was from rPeptide (Watkinsville, GA, 
USA). All peptides were ≥98% pure as confirmed by HPLC and mass spectrometry. Salts, 
buffers, hexafluoroisopropanol (HFIP), ThT, and other chemicals were from Fisher Scientific 
(Hanover Park, IL, USA) or Sigma-Aldrich (St. Louis, MO, USA). Quartz cuvettes for CD and 
fluorescence measurements were purchased from Starna Calls, Inc. (Atascadero, CA, USA). 
CaF2 FTIR windows were from Buck Scientific (East Norwalk, CT, USA). D2O (99.8% pure) 
was from Cambridge Isotope Laboratories (Andover, MA, USA). 
The lyophilized peptides were dissolved in HFIP at total peptide concentration of 50 μM, and 
CD spectra were monitored and measured on a J-810 spectropolarimeter equipped with a 
fluorescence attachment and a temperature controller (Jasco, Tokyo, Japan) at 250C, using a 4 
mm × 4 mm rectangular quartz cuvette. Under a gentle stream of nitrogen, the same peptide 
sample was used to remove the solvent. Then the sample was put inside of a desiccator chamber 
for around 1 h, and later the sample was put into J-810 spectropolarimeter to record CD spectra 
of dry peptides. Aqueous buffer (25-mM NaCl, 25-mM Na,K-phosphate, 20 μM ThT, pH 7.2) 
was then added to the dry peptide to obtain a peptide concentration of 50 μM, and the top of the 
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cuvette was wrapped with Parafilm and rotated on a Fisherbrand™ Multi-Purpose Tube Rotator. 
Three samples were conducted in parallel, that is, Aβ1–40, pEAβ3–40, and their 1:1 molar 
combination. At defined time points, CD (180–350 nm) and ThT fluorescence (400–600 nm with 
excitation at 435 nm) spectra were recorded on same peptide samples on the J-810 instrument. 
CD and fluorescence measurement were continued for 200 h. 
By plotting ThT fluorescence at 480 nm as a function of time of incubation in buffer the kinetics 
of fibrillogenesis was analyzed, and from the time dependence of the ellipticity ratio θρ/θβ, 
where θρ and θβ are the ellipticities representing unordered and β-sheet structures the kinetics of 
structural transitions were determined. These plots were fitted with single-exponential curves, 
which provided the rate constants and the limiting values of ThT fluorescence and secondary 
structural changes. 
For FTIR experiments on peptides in aqueous buffer, HFIP solution of the peptide was placed in 
small glass vials and the solvent was removed by desiccation. D2O-based buffer containing 25-
mM NaCl and 25-mM Na,K-phosphate, adjusted to pH* 6.8, was added to the dry peptide to 
achieve 50 μM concentration and stirred for 1.5 h using a magnetic stir bar. Here, pH* is the pH-
meter reading and corresponds to pD 7.2 after correction for the 0.4 pH unit isotopic shift.[93] 
70μL of the peptide solution was placed between two CaF2 disks (32 mm in diameter, 3 mm 
thick), separated by a 50 μm-thick Teflon spacer, and transmittance spectra were measured at 2 
cm−1 nominal resolution, using a Vector-22 FTIR spectrometer (Bruker Optics, Billerica, MA, 
USA) equipped with a liquid nitrogen cooled Hg-Cd-Te detector. Transmittance spectra of the 
blank buffer were measured and used as reference to calculate the absorbance spectra. 
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For FTIR measurements of dry peptides and those hydrated from gas phase, 35 μL of 200 μM 
HFIP solution of Aβ peptide were spread on the surface of a CaF2 disk and air dried, followed by 
desiccation for 15 min. The disk was installed on a sample holder, and FTIR transmittance 
spectra of the dry peptide were measured. This was followed by measurements of spectra of the 
peptide that was slowly hydrated by stepwise exposure to D2O vapor. D2O was used because 
H2O absorbs in the amide I region and thereby affects the conformation sensitive amide I band 
intensity and line shape. Around 10 mL of D2O in a small beaker was placed on a hotplate, 
covered with a larger glass beaker, and brought to ~900C to maximize evaporation. The peptide 
sample was placed inside the large beaker and thereby exposed to D2O vapors for a defined 
number of seconds, and then the spectrum of the partially hydrated peptide was measured. Care 
was taken to thermally isolate the peptide and avoid its heating during hydration from gas phase. 
Absorbance spectra were obtained using the transmittance spectrum of the bare CaF2 disk as 
reference. This procedure was continued multiple times until spectral changes in the amide I and 
amide II regions saturated. Precisely, the amide II absorbance band intensity at 1550–1530 cm−1 
gradually decreased due to amide hydrogen-deuterium (H/D) exchange and the amide I peak 
shifted to lower wavenumbers due to α-helix to β-sheet transition. The kinetics of structural 
changes were analyzed by plotting the ratio of β-sheet and α-helix structures against time of 
exposure to D2O vapor. The amount of α-helix at time t was considered proportional to the 
absorbance at α-helical wavenumber, αt / 𝐴𝑤 𝛼,𝑡. Values of α-helical wavenumbers, Wα, were 
determined based on the spectra of dry peptides, which were α-helical. Upon hydration by D2O 
vapor, 𝐴𝑤 𝛼,𝑡 gradually decreased and the β-sheet signal emerged and grew in intensity at β-sheet 
wavenumber, Wβ. Because the α-helical amide I band has nonzero intensity at Wβ, which we 
denote 𝐴𝑥,𝑡, the amount of β-sheet at time t is proportional to the rise in intensity at Wβ with 
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respect to 𝐴𝑥,𝑡, that is, 𝛽𝑡 ∝ 𝐴𝑤 𝛽,𝑡− 𝐴𝑥,𝑡. As the peptide hydration progresses, 𝐴𝑥,𝑡 decreases by 
a time-dependent factor 𝐴𝑤 𝛼,𝑡/𝐴𝑤 𝛼,𝑜: 














2.4.2 Preparation for Segmental Aggregation and Structural Propensities of Amyloid beta (Aβ) 
Peptide 
 
The synthetic A1-42 peptide was from Innovagen (Lund, Sweden) and was >98% pure. Synthetic 
peptide fragments, acetylated at N-terminus and amidated at C-terminus, was purchased from 
Peptide 2.0 Inc. (Chantilly, VA, USA) and were 98-99% pure, as verified by high performance 
liquid chromatography and mass-spectrometry. Hexafluoroisopropanol (HFIP), thioflavin-T 
(ThT), salts, buffers, and most of other reagents were purchased from Sigma- Aldrich (St. Louis, 
MO, USA) or Fisher Scientific (Hanover Park, IL, USA). Quartz cuvettes for circular dichroism 
(CD) measurements were from Starna Calls, Inc. (Atascadero, CA, USA). CaF2 windows for 
Fourier transform infrared (FTIR) studies were from Buck Scientific (East Norwalk, CT, USA). 
D2O (99.8% pure) was from Cambridge Isotope Laboratories (Andover, MA, USA).  
Circular dichroism (CD) and fluorescence spectra were measured using a J-810 
spectropolarimeter equipped with a fluorescence attachment and a temperature controller (Jasco, 
Tokyo, Japan) at 25 °C. Lyophilized peptides was dissolved in HFIP at a desired concentration 
and CD spectra were measured using a 4 mm  4 mm rectangular quartz cuvette. Then, the 
solvent was removed by desiccation and CD spectra of the dry peptide stuck on the walls of the 
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cuvette were measured. This was followed by addition of aqueous buffer (25 mM NaCl, 25 mM 
Na,K-phosphate, 20 M ThT, pH 7.2) to achieve a target peptide concentration. The cuvette was 
capped with a Teflon stopper, sealed with parafilm, and rotated on a Fisherbrand™ Multi-
Purpose Tube Rotator for several days. CD, ThT or intrinsic peptide fluorescence, and light 
scattering at 90 degrees were measured periodically on same sample, at pre-determined time 
pints, to follow the time dependence of structural changes and aggregation/fibrillogenesis of the 
peptides, using the multifunctional J-810 instrument. Measurements of these parameters on same 
samples in real time excluded sample to sample errors. For each peptide system, time-dependent 
spectroscopic measurements were repeated in three or four independent experiments.  
 ThT fluorescence was averaged between 475 and 485 nm, when excited at 435 nm, and 
plotted against time of incubation in buffer. For fluorescence RET experiments, incident light at 
220 nm was used for predominant excitation of phenylalanine as compared to tyrosine, and 
spectra were measured between 200 and 400 nm. For each donor/acceptor peptide pair, the 
fluorescence of individual peptides was measured at 100 M concentration, then spectra were 
recorded for the two peptides mixed at 50 M each to maintain the same total peptide 
concentration. For light scattering, incident light at 550 nm was used to avoid generation of 
fluorescence signal and scattered light intensity at 90 degrees was measured between 530 and 
570 nm. The signal intensity was averaged between 553 and 557 nm and plotted as a function of 
time.  
 The degree of inhibition of fibrillization of A1-42 by peptide fragments was evaluated 
based on ThT fluorescence data. Total saturating ThT fluorescence between 32 and 48 hours in 
the presence of both A1-42 and a given fragment was considered as a sum of fluorescence due to 
each component. Then, fluorescence owing to A1-42 fibrils in the presence of a fragment, F*, 
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was determined by subtracting the signal measured for the fragment alone from total 
fluorescence. Fluorescence signal measured for pure fragments was corrected for concentration 
before subtraction, i.e. multiplied by 0.7, assuming a linear relationship between fluorescence 
and peptide concentration. Inhibition percentage of A1-42 fibrillogenesis was calculated as IP = 
(1 – F*/F0)100%, where F0 is ThT fluorescence of A1-42 in the absence of fragments. 
For FTIR spectroscopy, HFIP solution of the peptide was placed in small glass vials and the 
solvent was removed by desiccation. D2O-baseb buffer containing 25 mM NaCl and 25 mM 
Na,K-phosphate, adjusted to pD 7.2, was added to the dry peptide to achieve 50 M 
concentration for the full-length peptide A1-42 and 50 M for the fragments. Peptide samples 
were stirred by a small (3 mm in diameter) magnetic stir bar over 100 hours. At defined time 
points, a 70-L peptide sample was placed between two CaF2 disks (32 mm in diameter, 3 mm 
thick), separated by a 50 m thick Teflon spacer, and FTIR spectra were measured at 2 cm-1 
nominal resolution, using a Vector-22 FTIR spectrometer (Bruker Optics, Billerica, MA, USA) 
equipped with a liquid nitrogen-cooled Hg-Cd-Te detector. Transmittance spectra of the blank 
buffer were measured and used as reference to calculate the absorbance spectra. For 
measurements of FTIR spectra of dry peptide sample, HFIP solution of the peptide was spread 
on a CaF2 disk, dried for 15 minutes in a desiccator, followed by measurement of the 
transmission spectrum. A transmission spectrum of the clean CaF2 disk was used as reference to 
calculate the absorbance spectrum. The instrument was continuously purged with dry air to avoid 
contribution of H2O vibrational/rotational features in the amide I region. Absorbance spectra of 
atmospheric H2O were measured separately and subtracted from spectra of peptides when such 
contribution was detected. 
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CHAPTER 3: RESULTS AND DISCUSSION 
 
3.1 Structure and Aggregation of Aβ1-40 and Pyroglutamylated pEAβ3-40 Separately and 
Combined. 
 
3.1.1 Kinetics of Fibrillogenesis: 
 
Due to the unstable, polymorphic structural behavior [94-96] of Aβ peptide, to avoid sample to 
sample errors, it is very important to measure the aggregation and structural change on same 
sample at same time. The kinetics of fibrillogenesis and the accompanying structural changes of 
Aβ1-40, pEAβ3-40, and their equimolar combination have been monitored by near-simultaneous 
measurements of Th-T fluorescence and CD spectra of same samples, using a spectropolarimeter 
with a fluorescence attachment. 
Incubation of all three peptide samples in aqueous buffer, Th-T fluorescence around 480 nm 
(λexcitation = 435 nm) gradually increased (Figure 3.1.1). To estimate fibrillogenesis 
propensities of the peptides, the time dependence of Th-T fluorescence and their amplitudes have 
been observed. For Aβ1-40, Th-T fluorescence reached ~0.23 relative units and then gradually 
decreased as shown in Figure 3.1.1 a, d. Single-exponential fit of the fluorescence increase 
yielded a rate constant of k = 0.029 ± 0.004 h−1 (Table 3.1.1) (here and below: average ± SD 
from triplicate experiments). It has been reported that for various forms of Aβ, the ascending and 
descending wings of the time dependence of Th-T fluorescence were observed which later 
interpreted in terms of formation of dense, Th-T-impermeable clumps of fibrils. [51,57,97] 
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Figure 3.1. 1: Th-T fluorescence spectra of 50 µM Aβ1-40 (a) pEAβ3-40 (b), and their equimolar 
combination (c) incubated in aqueous buffer containing 25 mM NaCl, 20 µM Th-T, 25 mM 
Na,K-phosphate (pH 7.2) at 25oC. All samples have been constantly mixed in a rotatory mixer 
between measurements for 200 hours. Only spectra at selected time intervals, indicated in panel 
a, are shown. Excitation was at 435 nm. Panels d, e, and f show the time courses of Th-T 
fluorescence and the single-exponential fits of data in panels a, b, c, respectively. For each 
peptide sample, data from a selected experiment are shown. The rate constants from these 
particular experiments are as follows: k = 0.031 h-1 for Aβ1-40 (d), k1 = 0.300 h-1 and k2 = 0.012 
h-1 for pEAβ3-40 (e), k = 0.095h-1 for the 1:1 mixture (f). 
For pEAβ3-40, the nature of time dependence of Th-T fluorescence was different compared to 
Aβ1-40. Two distinct kinetic components of Th-T fluorescence change over time have been 
observed (Figure 1b, e). With a rate constant of k1 = 0.320 ± 0.042 h−1, The first component was 
comparatively fast and reached 0.025 units. On the other hand, the second component with a rate 
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constant k2 = 0.014 ± 0.002 h−1, was slow and it reached an overall fluorescence intensity of 
~0.1 units at 200 hours of incubation in buffer. 
A very weak Th-T fluorescence was observed for the equimolar combination of the two peptides. 
The Th-T fluorescence reached around 0.025 units with single-exponential fit rate constant of k 
= 0.092 ± 0.015 h−1(Figure 3.1.1c, f and Table 3.1.1). All these data clearly indicate that compare 
to the peptide pEAβ3-40, Aβ1-40 undergoes fibrillogenesis through distinct pathway. Within 4 days 
of incubation in buffer, Aβ1-40 forms mature fibrils and then the fibrils incline to form 
supramolecular assemblies. The sample pEAβ3-40 rapidly obtains a conformation that produces 
low Th-T fluorescence compared to Aβ1-40. This indicates in the sample of pEAβ3-40, a very small 
fraction of the sample undergoes fibrillogenesis and the remaining follows with a much slower 
rate. An initial rapid increase of Th-T fluorescence of the pEAβ3-40 sample followed by a second, 
slower phase, a biphasic aggregation kinetics of pEAβ3-40 was observed in earlier 
experiments.[48] 
Table 3.1. 1: Rate constants of the increase in Th-T fluorescence of Aβ1-40, pEAβ3-40, and their 
equimolar combination upon incubation in aqueous buffer. 
Sample Th-T fluorescence 
Aβ1-40 k = 0.029 ± 0.004 h−1 
pEAβ3-40 k1 = 0.320 ± 0.042 h−1 
k2 = 0.014 ± 0.002 h−1 
Combination (1:1) k = 0.092 ± 0.015 h−1 
 
A resistance of fibrillogenesis was observed for the Aβ1–40/pEAβ3–40 equimolar combination.  
The Th-T fluorescence was saturated at a low level, similar to the initial phase of pEAβ3–40. 
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Overall, the data indicates that the small fraction of pEAβ3–40 sample forms fibrils but inhibits the 
formation of fibril in larger scale separately or in equimolar combination with Aβ1–40. 
 
3.1.2 Peptide Structure from Circular Dichroism 
 
To achieve monodisperse solution (free from preformed aggregates), the lyophilized form of 
Aβ1–40 and pEAβ3–40 peptides were dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP).[98] 
For each peptide and their equimolar combination, the CD spectra of HFIP solution were 
measured. A deep minimum around 205-208 nm and a weak minimum at 222 nm were observed 
from those spectra (Figure 3.1.2). The dry sample of all three peptides (after the solvent was 
removed) shows two minima at around 211 and 223 nm. The intensities of CD spectra for 
solvent samples and dry samples were almost equal. It has been reported in previous experiments 
that the minima around 208-211 nm and 221-224 nm are regions of α-helical structure of a 
peptide, produced by π–π* and n–π* electronic transitions. [99-101] This can only imply that in 
separated or in combination, the peptides in HFIP solvent and in dry state adopt α-helical 
conformation. For distorted α-helices or proteins containing several short helices with “distorted” 
edges are associated with red-shifted n–π* transition and larger θn–π*/θπ–π* ratios [102]. 
Additionally, red shift of n–π* transition can occur because of low polarity of the protein’s 
environment.[100] Hence, more flexible α-helices or large number of shorter α-helices are 
present in the peptide sample in dry state compared to peptide sample in HFIP can represented in 
terms of the slight red shift of the bands and significantly larger θn–π*/θπ–π* ratios. A lower 
polarity of the dry samples compared with HFIP solutions may also contribute to the difference. 
In APP, the sequences of Aβ are usually dehydrated which is the part of α-helical transmembrane 
segment of the protein [103,104]. So, for analysis of the structural transition following cleavage 
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and mixed with an aqueous solution, the α-helical conformation of dry peptide can serve as a 
reasonable initial point.  
 
Figure 3.1. 2: Circular dichroism spectra of Aβ1-40, pEAβ3-40, and their 1:1 molar combination 
dissolved in HFIP at 50 µM total peptide concentration and in dry state, as indicated. 
After exposed to aqueous buffer all samples of peptides (Aβ1–40, pEAβ3–40, and their equimolar 
combination) achieved the unordered structure as indicated by negative ellipticity between 198 
and 204 nm (Figure 3.1.3). This can only mean that the dry peptide sample is still in the wall of 
testing cuvette and the suspension from the wall of cuvette into the buffer can be monitored by 
observing the gradual increment of the signal intensity. After several hours of incubation, Aβ1–40 
sample developed a distinct CD spectra minimum at 217 nm (Figure 3.1.3a) which can be 
interpreted as the sample have transitioned from unorder structure to β-sheet structure. For 
pEAβ3–40 , the CD spectra minimum was at 222 nm (Figure 3.1.3b). Depending on peptide 
structural details, β-sheet n–π* band can reach 225 nm [77,80]. On the other hand, pEAβ3–40 may 
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contain a fraction of α-helical structure with n–π* transition around 222 nm[99,100] and/or type I 
or type II β-turns with CD minima between 220 and 225 nm.[69] For the equimolar combination 
of Aβ1–40 and pEAβ3–40, unordered conformation was acquired in aqueous buffer (negative 
ellipticity around 203 nm) then the sample have transitioned to β-sheet structure with CD 
minimum at 217 nm (Figure 3.1.3c). 
 
Figure 3.1. 3: Circular dichroism spectra of Aβ1-40 (a), pEAβ3-40 (b), and their 1:1 molar 
combination (c) incubated in aqueous buffer (25 mM NaCl, 20 µM ThT, 25 mM Na,K-
phosphate, pH 7.2) at 50 µM total peptide concentration for time periods indicated in panel a 
(color code is the same in panels a, b, c). Kinetics of transition from unordered structure to β-
sheet structure are presented in panel d as 𝜃205/ 𝜃217 for Aβ1-40 and the 1:1 combination and 𝜃205/ 
𝜃222 for pEAβ3-40. Lines are single-exponential fits with rate constants of 0.064 h-1 for Aβ1-40, 
0.109 h-1 for pEAβ3-40, and 0.049 h-1 for the combined sample. For each peptide sample, data 
from a selected experiment are shown. 
Even though there is no definitive isodichroic points were present in the CD data, the Aβ1–40 
spectra tend to converge at around 208 nm except for the first observation data since most of the 
peptide were still in the wall of testing cuvette (Figure 3.1.3a). Overall, the time dependence CD 
data suggested that the peptide sample Aβ1–40 most likely have two-component transition from 
the unorder structure to β-sheet structure. In contrast, of pEAβ3–40 and their equimolar 
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combination have more complex transition involving additional structural components, 
consistent with above discussion and with the two-phase kinetics of fibrillogenesis (Figure 3.1. 
1e). 
It has been observed that after 200 hours of incubation in buffer the peptide Aβ1–40, the 
ellipticities have got saturated in the range 217-222 nm after 100h of incubation faster than that 
of pEAβ3–40 and the 1:1 combination. This indicates that the quantity of β-sheet in Aβ1–40 exceeds 
that of pEAβ3–40 and the 1:1 combination by a factor of 1.5 to 2 (Figure 3.1.3a–c), in qualitative 
agreement with ThT fluorescence data (Figure 3.1.1). The time dependence of the ellipticity ratio 
θρ/θβ i.e the kinetics of the transition from unordered to β-sheet structure were quantify by the 
single-exponential curves with the following rate constants: k = 0.059 ± 0.010 h−1 for Aβ1–40, k = 
0.118 ± 0.015 h−1 for pEAβ3–40, and k = 0.045 ± 0.007 h−1 for the 1:1 molar combination (θρ and 
θβ are the ellipticities corresponding to unordered and β-sheet structures, respectively) (Figure 
3.1.3d and Table 3.1.2). 
Table 3.1. 2: Rate constants of the transition from unordered to β-sheet structure of Aβ1–40, 
pEAβ3–40, and their equimolar combination upon incubation in aqueous buffer. 
Sample Transition to β-sheet 
Aβ1–40 k = 0.059 ± 0.010 h−1 
pEAβ3–40 k = 0.118 ± 0.015 h−1 
Combination (1:1) k = 0.045 ± 0.007 h−1 
To avoid errors due to spectral noise at lower wavelength ellipticity at 205 nm was chosen for 
θρ. By analyzing all these data, it can say that the transition to β-sheet structure was faster for 
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sample pEAβ3–40 compared to Aβ1–40 and their equimolar combination undergoes slower 
transition to β-sheet structure than that of the two peptides separately. 
Overall, the CD data imply that (i) A larger fraction β-sheet of Aβ1–40 forms compare than 
pEAβ3–40 or the Aβ1–40/pEAβ3–40  (1:1) combination, (ii) pEAβ3–40 undergoes transition to β-sheet 
structure and may involve fractions of α-helix and/or β-turn structures during the transition, and 
(iii) the rate of the secondary structural transition decreases in the sequence: pEAβ3–40 > Aβ1–40 > 
Aβ1–40/pEAβ3–40 combination. 
The faster transition to β-sheet structure but lower intensity in ThT fluorescence (Figure 3.1.1b) 
and weaker CD intensity (Figure 3.1.3b) of pEAβ3–40 compared with Aβ1–40 can be interpreted as 
the former peptide forms intermediate β-sheet structure which can be represented as seeds for the 
growth of fibril. The two-phase ThT fluorescence of pEAβ3–40 (Figure 3.1.1e), fast nucleation 
phase and a slow elongation (fibril growth) phase interpretation is coherent with the former 
statement. In earlier study, it has been documented that for both pEAβ3–40 and pEAβ3–42 the 
aggregation initiates rapidly by a seeding process,71 is in agreement with our findings. 
From the red-shifted CD spectra of pEAβ3–40 (Figure 3.1.3b) it can be said that the sample 
pEAβ3–40 generates heterogeneous secondary conformation compared to unmodified peptide with 
the mostly β-sheet fibrillar structure. The equimolar combination of Aβ1–40/ pEAβ3–40 shows a 
similar phase of structural conversion as the initial short phase as pEAβ3–40, as it reaches around 
0.025 relative units of fluorescence. Furthermore, it stays as that level at least for 200 hours 
(Figure 3.1.1f). Even though the equimolar combination of Aβ1–40/ pEAβ3–40 might be able to 
produce mature fibrils at later time, the data implicated that the fibril formation had delayed by 
the presence of pEAβ3–40. Overall, the peptide sample kept in a prefibrillar form for slower time. 
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3.1.3 Peptide Structure from FTIR Spectroscopy 
 
To provide furthermore understanding into the secondary structural information, Aβ1–40, pEAβ3–
40, and their combination in aqueous buffer were monitored by FTIR spectroscopy. All the three 
samples show FTIR amide I band (Figure 3.1.4) after calculating the absorbance spectra from 
transmission spectrums. To enhance the amide I band second derivative resolution has been 
obtained where two major components was identified where 1673 cm−1 is assigned at as β-turn 
and other 1623 cm−1 is assigned to β-sheet. [105-107] The lower frequency at 1623 cm−1 had 
suggested as the formation of intermolecular, aggregated β-sheet. [106,108] The weaker 
components at 1657 and 1647 cm−1 can be assigned to residual α-helix and either unordered 
structure or amide-deuterated α-helix, respectively. Spectral features at 1636 and 1689 cm−1 
have assigned as a small fraction of intra-molecular β-sheet and the higher frequency counterpart 
of antiparallel β-sheet structure. [104–106] 
It has been reported in various studies that the FTIR is accomplished of differentiate between α-
helix, β-sheet, and β-turn structures way improved than that CD because the structural features 
are spectrally overlapped at the latter measurement. Thereby, FTIR analysis identifies the 
existence of β-turn and α-helical structures with the β-sheet structure not only in pEAβ3–40 
sample, as insinuated by CD data, but also in Aβ1–40 and their equimolar combination. The 
arrangement of β-sheets is at least partially antiparallel. These data also have suggested that the 
structural conformation of the equimolar combination of the two peptides looks like that of 
pEAβ3–40 more than Aβ1–40, coherent with CD and ThT fluorescence data. While it remains 
ambiguous whether various structural components are existent in same peptide molecules or 
different molecules adopt different structures, resulting in a heterogeneous peptide samples, 
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FTIR data show that the transition from the initial α-helical conformation to β-sheet structure is 
more intricate than a two-component transition. 
 
Figure 3.1. 4: FTIR spectra (a) and inverted second derivatives (b) of Aβ1-40, pEAβ3-40, and their 
1:1 combination, as indicated in panel (a), incubated in aqueous buffer of 25 mM NaCl, 25 mM 
Na,K-phosphate in D2O, pD 7.2, for 1.5 – 2.0 hours. 
 
3.1.4 Kinetics of Structural Transition upon Hydration from Gas Phase 
 
From previous recorded data, it can be said that in dry state the peptide Aβ adopts α-helical 
structure and transitions to a β-sheet conformation in aqueous buffer but neither the preliminary 
α-helical structure of Aβ that is just cleaved off from APP nor the fibrils β-sheet conformation 
exert the cytotoxic effect. The intermediate, transient prefibrillar structures are the major toxic 
species. Hence, it is very imperative to determine the structural features of intermediate forms of 
Aβ and analyze these transitions. Here, we have developed a novel biophysical approach to 
accomplish this goal, that is, slow hydration of the peptide from gas phase to slow down the 
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structural transition, coupled with FTIR spectroscopy to apprehend the intermediate structures. 
The peptide Aβ were dissolved in HFIP solutions. Then the sample was put on CaF2 glass 
window and dried the sample before the measurement of FTIR spectra. Then the sample was 
exposed to the D2O vapor for specific time periods for gradual hydration monitored by FTIR 
measurements. A spectral region covering the amide I and amide II modes was analyzed. The 
amide I band is generated mostly by the main-chain C=O stretching vibration and is 
conformation sensitive. On the other hand, the amide II band, results mostly from the amide N–H 
in-plane bending mode and is less sensitive to the peptide's secondary structure. The amide group 
is expected to undergo H/D exchange due to the presence of D2O, resulting in a ~100 cm−1 
down- shift of the amide II band and progressive decline of intensity in the 1560- to 1540-cm−1 
region. Thus, to evaluate peptide hydration spectral changes, the amide II region were used, and 
to measure the secondary structural changes, the amide I region were used. 
The dry sample of Aβ1–40 have a peak at 1657 cm-1(Figure 3.1.5a) in amide I region which 
indicate α-helical structure. When the sample was exposed to D2O vapor, the α-helical structure 
peak slowly decreased meanwhile a new component peak around 1630 cm-1 were generate which 
is the conformation wavenumber for β-sheet structure. Gradual hydration of the peptide by 
exposed to D2O vapor is monitored by observe the decrease of the amide II band intensity around 
1544 cm−1 , which suggests the amide H/D exchange. The single- exponential kinetics of the 
secondary structural change was characterized with a rate constant of k = 1.49 ± 0.37 min−1 and a 
limiting β-sheet/α-helix ratio of 1.58 ± 0.28 (Figure 3.1.5b, Table 3.1.3). 
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Figure 3.1. 5: (a): FTIR spectra of Aβ1-40 in dry state and after exposure to D2O vapor from 5 sec 
to 5 min, as indicated. (b): Dependence of β-sheet/α-helix ratio on time of hydration from gas 
phase is fitted with a single-exponential line with a rate constant of k =1.49 min-1. 
It has been reported in various studies that the peptides Aβ and pEAβ are existed in brain cell 
individually as well as combined, heterogeneous complexes [28,31]. So, it is very essential to 
distinguish the structural conformation of Aβ1–40 and pEAβ3–40 separately and intermixed. 
Though circular dichroism (CD) is proficient of determination of structure of peptides but it is 
futile when the dissection of the structures of both peptides in a binary sample necessary which 
can be done by using isotope-edited FTIR spectroscopy. In this method uniformly 13C-labeled 
Aβ1–40 (13C-Aβ1–40) and unlabeled pEAβ3–40 were used for intermixed peptides. 13C-labeling of a 
protein results in a 40–45 cm−1 downshift of its amide I band, which stipulates spectral resolution 
of both 13C-labeled and unlabeled proteins when combined in one sample.[107] 
In FTIR spectroscopy, 13C-Aβ1–40 show a peak at 1616 cm-1 in the amide I region which 
indicates α-helical structure and illuminating the isotopic shift of the vibrational frequency 
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(downshift by 41 cm−1). After exposed by D2O vapor, the sample peak at 1616 cm-1 gradually 
decrease and a new peak arise around 1588 cm-1, the β-sheet component in amide I region. 
During the measurement it has been observed that the amide I region also confined a component 
around 1677 cm−1 that was not perceptive to amide H/D exchange. This feature has been 
reported previously in 13C-Aβ1–42 and other peptides and assigned to residual trifluoroacetic 
acid.[85] As expected, the amide II band shows downshift from 1544 cm-1 to 1529 cm-1 due to 
13C-labeling to unmodified peptide. The amide II had exhibited multiple spikes in some 
measurements, which are produced by the vibrational/rotational hyperfine structure of D2O 
bending mode [109,110] and do not comprise spectral noise. Amide H/D exchange was 
monitored in the gradual regression of amide II band intensity and correlated with the transition 
from α-helix to β-sheet conformation, as described in Figure 3.1.6d. The kinetics of α-helix to β-
sheet transition was illustrated with a single-exponential rate constant k = 1.31 ± 0.25 min−1 and 




Figure 3.1. 6: FTIR spectra of 13C-Aβ1-40 (a), pEAβ3-40 (b), and their 1:1 combination (c) in dry 
state (black) and exposed to D2O vapor from 5 s (dark blue) to 5 min (red). The color code is the 
same as in Figure 5. Kinetics of α-helix to β- sheet transitions of 13C-Aβ1-40, pEAβ3-40 and the 
combination are presented in panels d, e, f, respectively. Data are fitted with single-exponential 
lines with rate constants k = 0.93 min-1 for 13C-Aβ1-40 and k = 1.29 min-1 for pEAβ3-40, measured 
individually. For the combined peptide sample, structural transitions of 13C-Aβ1-40 and pEAβ3-40, 
following the short lag period, are characterized with rate constants k = 1.84 min-1 and k = 1.88 




Table 3.1. 3: Rate constants (k, min−1) and limiting β-sheet/α-helix ratios ((β/α)max) for α-helix 
to β-sheet transitions of Aβ1–40, 13C-Aβ1–40, and pEAβ3–40 separately and in equimolar 
combination upon exposure to D2O vapor of dry peptide samples. 
Sample Separate 











Aβ1-40 1.49 ± 0.37                    1.58 ± 0.28 N/A                                       N/A 
13C-Aβ1-40 1.31 ± 0.25                    1.72 ± 0.33 1.67 ± 0.34                       1.22 ± 0.23 
pEAβ3-40 1.14 ± 0.19                  1.25 ± 0.21 1.74 ± 0.26                       0.37 ± 0.06 
 
The dry sample of pEAβ3–40 shows amide I peak at around 1656 cm-1 and after exposed to D2O 
vapor the new peak arise at 1629 cm-1 (Figure 3.1.6b), indicating the transition from the α-
helical conformation to β-sheet structure. Simultaneously, hydration was supplemented with 
decline in the intensity of the amide II band around 1542 cm−1 because of amide H/D exchange. 
The kinetics of α-helix to β-sheet transition was illustrated with a single-exponential rate 
constant k = 1.14 ± 0.19 min−1 and a limiting β-sheet/α-helix ratio of 1.25 ± 0.21 (Table 3.1.3). 
After compare the saturating values of β-sheet/α-helix ratios of pEAβ3–40 with those of 13C-
labeled or unlabeled Aβ1–40, it indicates pEAβ3–40 contain less β-sheet and more α-helix when 
aqueous solution was added which is consistent with weaker ThT fluorescence and CD signal of 
this peptide (Figures 3.1.1b, e and 3.1.3b). The equimolar combination of 13C-Aβ1–40/pEAβ3–40 
display two peaks in amide I region around at 1658cm-1 and 1616cm-1 (Figure 3.1.6c) in dry state 
indicates the α-helical structure of both unlabeled and 13C-labeled peptides respectively. After 
exposed to D2O vapor those α-helical peaks diminished and new peaks develop at around 1643 
cm-1 and 1594 cm-1 and observe increment of intensity after time interval increase which 
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characterize β-sheet structure for unlabeled pEAβ3–40 and 13C-Aβ1–40, respectively. The amide II 
band arisen at around 1540 cm-1 to 1530-cm−1 region and declined upon exposure to D2O vapor 
due to amide H/D exchange. In a combined sample, the kinetics of α-helix to β-sheet transitions 
showed a longer lag time compared with that seen for pEAβ3–40 (Figure 3.1.6e and 3.1.6f) and 
were characterized with single-exponential rate constants k = 1.67 ± 0.34 min−1 and k = 1.74 ± 
0.26 min−1 and limiting β-sheet/α-helix ratios of 1.22 ± 0.23 and 0.37 ± 0.06 for 13C-Aβ1–40 and 
pEAβ3–40, respectively (Figure 3.1.6f, Table 3.1.3).  
There are several interesting effects reveal while comparing the spectra of individual peptides 
with their equimolar combination. The first thing it was observed that the frequencies of β-sheet 
structure of individual peptides (1588 and 1629 cm−1 for 13C-Aβ1–40 and pEAβ3–40, respectively) 
considerably lower than those of their equimolar combination (1594 and 1643 cm−1). This kind 
of frequency shifts may occur because of (a) transition dipole coupling (TDC) effects, that is, 
frequency shifts due to interactions between amide I oscillators [111,112] and (b) structural 
differences between individual and combined peptides. It has been reported that the unperturbed 
amide I frequency between 1680 and 1672 cm−1 is generated by Unordered proteins with no H-
bonding and no interaction between amide oscillators. [103-106] The specific secondary 
structures formation causes the oscillators of amide I into one-another’s force field, resulting in 
transition dipole coupling (TDC) and producing characteristic frequencies, such as those 
presented by individual peptides (Figure 3.1.6a, b). The resultant of β-sheet signals at higher 
frequencies might occurred because of mutual intercalations of 13C-Aβ1–40 and pEAβ3–40 
molecules intrude with TDC between both 13C-labeled and unlabeled amide units. Various 
studies suggested that aggregated β-sheets with intramolecular H-bonding generate amide I 
signal at 10- to 15-cm−1 higher frequencies than intermolecular β-sheets. [106,108] So there is 
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possible fact developed in the difference between the observed frequencies of β-sheet structure 
of the peptides in separately and combined. The peptides format intermolecular β-sheets when it 
hydrated individually and format β-hairpin-like structures with intramolecular H-bonding when 
hydrated combined. Here, equimolar combined unlabeled peptides would generate higher amide 
I frequency while in aqueous buffer compared to that of the peptides in separately. Oppose to 
this probability, the data of figure 3.1.4b display that Aβ1–40, pEAβ3–40, and the 1:1 combination, 
all three samples produce generate β-sheet peaks at same frequencies: a major one at 1623 cm−1 
and a minor one at 1636 cm−1. Therefore, the upshifted amide I frequencies of the combined 
sample (Figure 3.1.6c), can be completely ascribed to TDC effects. This information insinuates 
that the 13C-Aβ1–40 and pEAβ3–40 equimolar combination produces intertwined conformation, 
diminishing TDC between like molecules and thus the higher vibrational frequencies are 
generated. Previous study had been done with FTIR analysis on 13C-Aβ1–42 and pEAβ3–42 where 
similar amide I spectral upshifts were identified for both peptide in their combination.[113] 
Although, in contradiction of the 13C-Aβ1–40/pEAβ3–40 system, the spectra of individual peptide 
had showed residual higher frequency signals, which became primary in samples are in mixed, 
suggesting that the spectral upshift could not explained by TDC alone. The separated Aβ1–42 and 
pEAβ3–42 peptides form amide I at lower frequencies represents intermolecular H-bonding, 
however in combination, they form intramolecular H-bonding. The study of Aβ1–40/pEAβ3–40 
system has shown the spectral shift, which is totally result from TDC effects, inhibiting 
propositions of transition in the H-bonding pattern while the peptides in combination. 
Moreover, the peak at 1643 cm-1 for pEAβ3–40 in equimolar combination when exposed in D2O 
vapor is considerably weaker than that of 13C-Aβ1–40, additionally the spectrum shows an added 
peak at 1667 cm-1(Figure 3.1.6c, red line). This can be assigned to a more flexible αII-helix that 
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absorbs at higher frequencies, in the 1667- to 1665-cm−1 spectral region, [114,115] proposing 
that pEAβ3–40 sustains a fraction of disordered α-helix structure at the expense of β-sheet when in 
aqueous environment. This result indicates that however 13C-Aβ1–40 transition from α-helix to β-
sheet structure in the combined sample, pEAβ3–40 forms β-sheet structure only partially and 
maintains a fraction of flexible, or disordered, α-helical structure. 
Afterward, the data that were collected from FTIR spectroscopy have been analyzed to determine 
the β-sheets of hydrated peptide were either parallel or antiparallel. The second derivatives of 
spectra of dry and hydrated samples were done graphically which emphasize the α-helical peaks 
of dry peptides and the presence of β-sheet features upon hydration (Figure 3.1.7). For individual 
peptides, in addition to the major β-sheet component at 1629–1628 cm−1 (1586 cm−1 for 13C-
Aβ1–40), a spectral feature is observed at 1695 cm−1 (1651 cm−1 for 13C-Aβ1–40) (Figure 3.1.7a–
c), which is represented to the high-frequency counterpart of antiparallel β-sheet.[105-107] For 
equimolar combined sample, the spectra of β-sheet peaks for 13C-Aβ1–40 and pEAβ3–40 are 
demonstrated at 1592- and 1645- to 1635-cm−1 regions, respectively, but the feature in the high-







Figure 3.1. 7: Inverted second derivatives of FTIR spectra of Aβ1-40 (a), 13C-Aβ1-40 (b), pEAβ3-40 
(c), and the 1:1combination of 13C-Aβ1-40 and pEAβ3-40 (d) in dry state (black line) and exposed 
to D2O vapor for 10 s, 20 s, 30 s, 1 min, 2 min, 3 min, 4 min, and 5 min (gray to red), derived 
from spectra shown in Figures 5 and 6. The wavenumbers of most prominent spectral features 
are indicated. 
 
This finding insinuated that the individual peptides obtain antiparallel β-sheets structure in 
presence of aqueous system and form mostly parallel β-sheets when they are in combination 
together. Nonetheless, FTIR data on the peptides in bulk buffer exhibit the high-frequency 
antiparallel β-sheet component in the combined sample as well (Figure 3.1.4b). There is a 
possibility that the peptides form mixed antiparallel and parallel β-sheets, with a shift toward the 
parallel β-sheets in the combined sample hydrated from gas phase, as stated for Aβ1–40 
aggregated on ganglioside-containing membranes.[116] Spectral features at 1666–1664 and 1651 
cm−1 (1620 and 1604 cm−1 for 13C-Aβ1–40) are assigned to residual disordered or regular (amide 
deuterated) α-helical structures, respectively. 
 
Lastly, the transition’s kinetics from α-helix to β-sheet for 13C-Aβ1–40 and pEAβ3–40 their 
equimolar combination implies that both peptides develop β-sheet structure quicker than the 
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separated peptides except the β-sheet/α-helix ratios reach low quantitatively and this tendency is 
much more noticeable for pEAβ3–40 compare to that of 13C-Aβ1–40 (Table 3.1.3). Furthermore, 
the formation of onset β-sheet structure is led by a lag time for pEAβ3–40 but not 13C-labeled or 
unlabeled Aβ1–40, and the lag period is slower for both peptides in the mixed sample (Figure 
3.1.6d–f). The repetition of low β-sheet propensity of pEAβ3–40 and indicates mutual suppression 
of β-sheet fibril formation by the two peptides. The data collected from isotope edited FTIR 
spectroscopy corroborate the finding from CD and ThT fluorescence studies that compare to the 
peptide Aβ1–40, the transition from α-helix to β-sheet conformation pEAβ3–40 comprises a reduced 
fraction of β-sheet fibrils. Previous studies suggested that Aβ1–40 have greater helical propensity 
compared with pEAβ3–40 in H2O/TFE environment [70,117] evidently indicate the helix forming 
effect TFE and are not in disagreement with present data collected in pure aqueous medium. In 
the equimolar combination, pEAβ3–40 maintains a fraction of α-helical structure and decreases β-
sheet fibril formation propensity compare to Aβ1–40. The inclination of pEAβ3–40 to inhibit 
fibrillogenesis may play a role in its increased cytotoxicity as the prefibrillar assemblies are 
known to employ the major toxic effect.  
 
3.2 Segmental Aggregation and Structural Propensities of Amyloid beta (Aβ) Peptide 
 
Structural and aggregation properties of the parent A1-42 peptide and seven overlapping peptide 
fragments have been studied, i. e. A1-10 (P1), A6-15 (P2), A11 -20 (P3), A16 -25 (P4), A21 -30 
(P5), A26 -36 (P6), and A31 -42 (P7), as shown in Figure 3.2.1, to identify the region(s) of A 





Figure 3.2. 1: Overlapping Aβ peptide fragments and the parent Aβ1-42 peptide, presented as 
single single-letter sequences, along with the theoretical isoelectric point (pI) values. 
3.2.1 Peptide Secondary Structure from FTIR Spectroscopy 
 
FTIR spectroscopy was used to analyze the structural transitions in the peptides.  
To disperse possible pre-existing aggregates, the lyophilized peptides were dissolved in 
hexafluoroisopropanol (HFIP).[98] A1-42 peptide in HFIP solution was span over a CaF2 disk , 
air-dried with gentle stream of N2 gas and desiccated for 15 minutes, followed by measurement 
of Fourier transform infrared (FTIR) spectra. The dry peptide obtains -helical structure 
displayed by a sharp amide I peak at 1658 cm-1 (Figure 3.2.2). Most of the A sequence 
corresponds to the transmembrane -helix embedded in neuronal membranes, before cleavage 
from APP. [104] Therefore, this result is coherent with the intrinsic -helical propensity of the 
A1-42 sequence in dry state. Instead, determining the structure of the dehydrated peptide is 
essential for analysis of structural transitions once the peptide is exposed to an aqueous medium. 
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Figure 3.2. 2: FTIR spectrum of Aβ1-42 dried on a CaF2 disk from 50 𝜇M HFIP solution. Amide I 
and amide II peaks are located around 1657 cm-1, amide II around 1537 cm-1, respectively. 
 
Figure 3.2. 3: FTIR spectra at indicated times of incubation in D2O-based buffer (25 mM NaCl, 
25 mM Na,K-phosphate, pD 7.2) for Aβ1-42 (a) and peptides P1 (b), P2 (c), P3 (d), P4 (e), P5 (f), 
P6 (g), and P7 (h)  at 25oC. The concentrations of the peptides were 50 µM for Aβ1-42 and 100 
µM for the fragments. Times of incubation in buffer of all fragments are indicated in panel b. 
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Afterward, A1-42 and the seven peptide fragments in HFIP solution were dried separately in 
glass vials and aqueous (D2O) buffer was added to reach concentrations of 50 M for A1-42 and 
100 M for the peptide fragments. With a small magnetic stir bar, the samples were constantly 
stirred, and spectra of 70 L volume of sample were measured periodically over 100 hours to 
observe structural changes of the peptides. Initially, the amide I spectrum of A1-42 exhibited two 
noticeable components at 1672 and 1647 cm-1, suggesting mostly -turn and unordered or loop 
conformations [107] (Figure 3.2.3). the peak at 1647 cm-1 was gradually replaced by a 
component at 1627 cm-1, upon incubation in buffer, suggesting the formation of intermolecular 
-sheet structure [107] which is consistent with the fibrillar structure of A1-42 containing -sheet 
and -turn/loop conformations [118-120] (Figure 3.2.1) and implies that through intermolecular 
H-bonding, formation of turn/loop structures leads aggregation and fibrillogenesis. 
The distinct structural transitions were observed from the peptide fragments when they 
add in aqueous buffer. Each peptide fragments except P7 initially generates significant fraction 
of -turn structure in supplement to irregular structure, indicated by amide I components in 
1672-1670 cm-1 and 1640 cm-1 regions, respectively (Figure 3.2.3). Only P3 and P6 displayed -
sheet component at 1628-1623 cm-1, among these 6 peptides (Figure 3.2.3d, g). In case of P3, 
both -turn and -sheet structures developed at the expense of irregular structure (Figure 3.2.3d), 
whereas in P6 the -turn became the principal structure upon continued incubation in buffer 
(Figure 3.2.3g). P7 exhibited a distinctive behavior; it rapidly produced -sheet structure with a 
distinctive peak around 1626 cm-1, which gradually shifted to higher wavenumbers possibly 
reflecting transition to turn and/or -helix structures. Therefore, peptides P3, P6, and P7 display 
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-sheet formation propensity with diverse dynamics of structural transitions while the other four 
peptides incline to adopt −turn/loop conformations. 
 
3.2.2 Peptide Secondary Structure from Circular Dichroism (CD) Spectroscopy 
 
For further analysis, the structural transition of peptides in aqueous buffer were monitored by a 
complementary biophysical method, circular dichroism (CD). The question “how the structural 
transitions of the peptides are corelated to fibrillogenesis”, was focused at the same time which 
was accomplished by simultaneous measurements of CD spectra, light scattering, and thioflavin-
T (ThT) fluorescence of same peptide samples in aqueous buffer for over 100 hours. 
 




Figure 3.2. 4: CD spectra of Aβ1-42 (a), P1 (b), P2 (c), P3 (d), P4 (e), P5 (f), P6 (g), and P7 (h) 
dissolved in HFIP (solid) and in dry state (dotted). The concentration of Aβ1-42 in HFIP is 35 µM 
and that of the fragments is 100 µM. The spectra of dry peptides are scaled up by a factor of 5 
for better comparison. Averaged from three experiments. 
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A deep minimum at 204 nm and a shoulder around 220 nm (Figure 3.2.4) were generated for the 
CD spectrum of the full-length A1-42 peptide in HFIP, suggesting the presence of type I and II 
-turns, -strand, and possibly -helix conformations [102,121]. CD spectra of seven peptide 
fragments exhibited two negative ellipticities as well. CD spectra of seven peptide fragments 
exhibited two negative ellipticities as well. The stronger component arisen in the 205-208 nm 
region (P1 and P2) or 195-200 nm region (P3 through P7) (Figure 3.2.4b-h), appointed to -turn 
and unordered structures, respectively [91,99-100]. Between 220 and 230 nm, the weaker 
component was detected which can be assigned to -helix,  -turn and -strand conformations.  
 
By desiccation the solvent was removed and CD spectra of dry peptides were measured. Upon 
drying the structure of each peptide changes significantly. A1-42 adopted mostly -helical 
structure, demonstrated by a negative component at 223 nm and weaker one at 208 nm, which 
are produced by the n-* and -* electronic transitions [100,102]. The similar CD spectra were 
observed for P1, P3, and P6. The weaker intensity of the -* transition can be accredited to a 
more flexible or distorted -helix [102]. For peptides P4 and P5, the -* transition was 
stronger, suggesting the formation of more stable -helix in CD spectra. Just one component 
around 220-223 nm was shown for dry peptides P2 and P7, which is most likely to represent 
type-I -turn and -strand structures [99,121]. 
 The aqueous buffer was added to the peptides in dry state and structural transitions were 



















Figure 3.2. 5: CD spectra of 50 µM Aβ1-42 (a) and 100 µM of peptides P1 (b), P2 (c), P3 (d), P4 
(e), P5 (f), P6 (g), and P7 (h) constantly stirred by a tube rotator in buffer (25 mM NaCl, 25 mM 
phosphate, pH 7.2) for time periods indicated in panel (a) for Aβ1-42 and in panel (b) for all 
fragments. All measurement were conducted at 25oC. Average data from three independent 
experiments. 
Initially, the CD spectra showed a shallow negative band around 217 nm for A1-42, which 
became a well-defined band accompanied with a positive component of nearly equal intensity 
around 200 nm upon incubation in buffer for up to 48 hours, clearly indicating formation of -
sheet structure (Figure 3.2.5a). The peptide fragments were examined for longer time since their 
structural transition occurred at slower rate. Peptide fragments P1, P2, P4, and P5 exhibit strong 
negative ellipticity around 200 nm and weaker one between 225 and 235 nm (217 nm for P2), 
indicating these peptides assume mostly unordered conformation with fractions of -turn/-
strand structures (Figure 3.2.5 b,c,e,f). On the other hand, peptides P3, P6, and P7 readily 
adopted defined secondary structures within less that 1 hour (Figure 3.2.5 d,g,h). The CD spectra 
of these three peptide fragments exhibit a negative n-* band around 220-225 nm of moderate 
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intensity and strong positive ellipticity in the -* region (<200 nm). These spectral features can 
be assigned to twisted -sheet structure, as the intense -* transition is indication of twisted -
strands, and the n-* band can be significantly red-shifted depending on the degree of strand 
twist [91,99,100,102,122,123]. Since the long optical path-length (4mm) of the cuvette was used 
for simultaneous light scattering and fluorescence measurements with CD spectra, the excessive 
noise below 200 nm was observed. Nevertheless, this does not undermine above interpretations 
of CD spectra in terms of peptides’ structural features. 
From FTIR and CD measurements, some differences have been observed in peptide structures, 
such as different relative contents of -turn and irregular structures. This divergence might occur 
due to non-identical sample preparation and handling protocols, as A structure is exquisitely 
sensitive to sample preparation conditions, including the method of sample stirring [94]. 
Furthermore, both N-terminal acetylation and C-terminal amidation initiate additional amide 
bonds that generate FTIR signal in the unordered region, i.e. between 1650 and 1638 cm-1. 
Nevertheless, both FTIR and CD data uncover important common structural trends of these 
peptide fragments, i.e., P3, P6, and P7 stand out by displaying strong -sheet propensity, 
resembling the parent peptide A1-42, whereas other peptides P1, P2, P4, and P5 incline to stay in 
-turn or unordered conformations.  
 
 
3.2.3 Aggregation and Fibrillogenesis 
 
To examine the kinetics of aggregation and fibrillogenesis of the peptides in aqueous buffer, ThT 
fluorescence and static light scattering at 90 degrees were monitored. To exclude sample to 
sample errors, these measurements were conducted in parallel with CD on same samples, which 
permitted analysis of structural changes, peptide aggregation and fibril formation in real time. 
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The indication of increase in ThT fluorescence around 480 nm when excited at 435 nm (Figure 
3.2.6 a,b) suggest that without delay A1-42 underwent fibrillogenesis . By around 1 day of 
incubation in buffer with constant stirring on a rotary mixer, ThT fluorescence was reached 
saturated state. At 550 nm light scattering increased with steeper initial rate and approached 
saturation by 10-20 hours of incubation (Figure 3.2.6 c,d). The difference in the initial kinetics of 
fluorescence and light scattering may reflect rapid formation of non-fibrillar aggregates that do 

















Figure 3.2. 6: ThT fluorescence with excitation at 435 nm (a) and light scattering with incident 
light at 550 nm (c) of 35 µM Aβ1-42 in buffer (25 mM NaCl, 25 mM Na,K-phosphate, pH 7.2) 
stirred by a tube rotator for time periods indicated in panel (a). Time dependence of ThT 
fluorescence averaged between 475 and 485 nm and of light scattering averaged between 550 
and 555 nm are presented in panels (b) and (d), respectively. Average data from three 
independent experiments. 
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A very weak ThT fluorescence was monitored for peptide fragments P1, P2, P4, and P5 (Figure 
3.2.7a,b,d,e). Peptides P3 and P6 produced higher level of ThT fluorescence, and peptide 7 
constructed maximum ThT fluorescence (Figure 3.2.7c,f,g), unraveling a sequence of  





















Figure 3.2. 7: ThT fluorescence spectra of P1, P2, P3, P4, P5, P6, and P7 (panels 1 through g, 
respectively) with excitation at 435 nm, at 25oC. Time of incubation of peptide samples in buffer 
(25 mM NaCl, 25 mM Na,K-phosphate, pH 7.2) at 100 µM concentration with constant stirring 
by a tube rotator is as follows: 0.1 h (dark blue), 2.0 h (light blue), 4.0 h (turquoise), 16.0 h 
(green), 40.0 h (yellow), 64.0 h (orange), 104.0 h (red). Panel h shows the time dependence of 
ThT fluorescence averaged between 475 and 485 nm for all seven peptides. Average data from 
three independent experiments. Error bars are shown only for P1, P3, P4, P6, P7 to maintain 
clarity. Error bars for P2 and P5 are of similar magnitude as for those of P1 and P4.  
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Contemporary light scattering measurements implied relatively weak signal for peptides P1, P2, 




Figure 3.2. 8: Time progression of light scattering spectra of peptides P1 (a), P2 (b), P3 (c), P4 
(d), P5 (e), P6 (f), and P7 (g) at 100 µM. Color code in panels (a) through (g) is the same as in 
Figure 3.2.7. Panel (h) shows time course of light scattering for all seven peptides. Standard 
deviation bars from three experiments are only shown for selected peptides to maintain clarity. 
Error bars for other peptides are of similar magnitude. 
 
The peptide fragments P1,P2,P4 and P5 exhibit little ThT fluorescence but substantial light 
scattering indicates the formation of non-fibrillar aggregation. Greater level of ThT fluorescence 
by P7 compared to P3 and P6 but comparable light scattering (Figure 3.2.7h and 3.2.8h) 
insinuates a more extensive ThT binding capacity of P7, probably due to its higher 
hydrophobicity and/or a larger number of amino acid residues. Generally, these data provide 
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evidence that peptides P3, P6, and P7 possess significant aggregation/fibril formation capability 
as compared to the other four A peptide fragments. In concurrence with structural data, it 
appears that the aggregation/fibrillogenesis property of these peptides correlates with their -
sheet formation ability.   
 
3.2.4 Effects of Aβ Fragments on Aβ Fibrillogenesis 
 
If the strong fibrillogenesis propensity were demonstrated by some of peptide fragments, they 
might be capable of intercalate into the assemblies of the full-length parent peptide by binding to 
respective stretches and thereby impede with its aggregation. Fibrillogenesis of A1-42 was 
measured in the absence and presence of all seven peptide fragments at two-fold molar excess to 





Figure 3.2. 9: Time progression of ThT fluorescence spectra (excitation= 435 nm) of Aβ1-42 in 
aqueous buffer at 35 M (a), and with 70 M of P1 (b), P2 (c), P3 (d), P4 (e), P5 (f), P6 (g), and 
P7 (h). Buffer: 25 mM NaCl + 25 mM phosphate (pH 7.2). 
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In the presence of peptides P1, P2, P4, P5, and P7, ThT fluorescence of A1-42 samples 
progressively increased and levelled off by 48 hours of incubation with little effect of these 
fragments (Figure 3.2.9 b,c,e,f,h). The intensity values for wavelength 480 nm vs time of 
incubation were plotted for every sample. Here it has been observed that the fluorescence 
intensity gradually increased over increase of incubation time for samples of Aβ1-42 mixed with 
P1, Aβ1-42 mixed with P2, Aβ1-42 mixed with P4, Aβ1-42 mixed with P5, Aβ1-42 mixed with P7 and 
reach more than 0.1 arbitrary units where Aβ1-42 mixed with P3 and Aβ1-42 mixed with P6 
samples fluorescence around 480 nm were increase initially up to incubation for 16 hours but by 
24 hours of incubation the intensity decreases get saturated for further observation by remaining 
the intensity around 0.025 arbitrary units.  In contrast, P3 and P6 strongly reduced the level of 
ThT fluorescence (Figure3.2.9 d,g). Despite relatively large standard deviations among three 
experiments, which reflects the inherent polymorphism of A, the distinctive inhibitory effects 






Figure 3.2. 10: Time dependence of ThT fluorescence at 480 nm (excitation= 435 nm) of Aβ1-42 
alone and in the presence of 2-fold molar excess of peptides 1 to 7, as indicated. Buffer: 25 mM 
NaCl + 25 mM phosphate, pH 7.2. 
Quantitative evaluation of inhibition of A1-42 fibril formation by peptide fragments was 









Figure 3.2. 11: Inhibition percentages for P1 through P7 calculated based on ThT fluorescence 
data (Figures 3.2.6, 3.2.7, 3.2.10) averaged between 32 and 48 hours of incubation of Aβ1-42 
alone and with each peptide fragment at 2-fold molar excess in buffer (25 mM NaCl, 25 mM 
Na,K-phosphate, pH 7.2). See details in Materials and Methods. 
 
P3 and P6 strongly inhibited A1-42 fibrillization by 80.59.0% and 77.75.8%, respectively 
(Figure 3.2.11). Peptides P2 and P7 exhibited moderate inhibitory potencies (IP = 18.82.1% 
and 28.73.8%, respectively), and the other three peptides (P1, P4, and P5) were not potent 
inhibitors (IP < 5.0%).    
 
This work details an analysis of structural and aggregation propensities of A1-42 fragments and 
their effects on A1-42 fibrillogenesis. The results facilitate a better understanding of segment-
specific properties of A1-42 and distinguish peptide fragments capable of inhibiting its 
aggregation. We selected 10 to 12-residue overlapping fragments because fragments shorter than 
10 residues might be incapable to demonstrate vigorous secondary structure formation and 
fibrillogenesis abilities because of insufficient length. Although short A fragments comprising 
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6-8 residues have been shown to adopt parallel or antiparallel -sheets in crystal form [124,125], 
the hydrophobic C-terminal sequences of A1-42 containing eight amino acid residues, as well as 
an 11-residue stretch (A32-42), did not aggregate into -sheet fibrils in aqueous buffer even at 
concentrations exceeding 100 M [83]. On the other hand, use of overlapping sequences was 
important for characterization of segments at boundaries of consecutive stretches; properties of 
the boundary between P(i) and P(i+2) were reflected in P(i+1), which covers the C- and N-
termini of flanking sequences.   
 
Peptides P1 and P2 represent the N-terminus of A, which has been consistently found in 
unordered conformation in the context of A1-40 or A1-42 [94,118,120,126]. The A1-8 fragment 
was found in extended coil confirmation in complex with a monoclonal antibody [94]. Despite 
its proposed role in stabilizing A fibrils [127], above data and our findings indicate that the N-
terminus of A is intrinsically unordered and unable to undergo fibrillogenesis. This feature is 
evidently related with the amino acid composition of these segments; the paucity of nonpolar 
side chains and the excess negative charge (pI 4.54 and 5.72 for P1 and P2, respectively) may 
inhibit aggregation due to electrostatic repulsion and absence of hydrophobic interactions. P1 is 
also a poor inhibitor of A1-42, whereas P2 demonstrates moderate inhibitory activity (Figure 
3.2.11), which probably stems from its C-terminal part, as P3 is highly aggregation prone and a 
potent inhibitor of A1-42 fibrillogenesis. 
 
 The P3 segment corresponds to one of the two major -strands of A1-40 fibrillar structure 
A1-42 [94] (Figure 3.2.1). The whole P3 sequence or at least its central part are in -strand 
conformation in fibrils formed by of A1-42 as well [118-120] (Figure 3.2.1). P3 has one glutamic 
acid (Glu) and one lysine (Lys) residues and nearly zero net charge (pI = 7.01). These features 
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would allow the peptide to form -strand-like non-H-bonded out of register aggregates in 





Figure 3.2. 12: Proposed mode of aggregation of P3. Red, blue, and green side chains are those 
of Glu11, Lys16, and His 13 and 14. All other side chains are omitted for clarity. The monomer 
𝛽- strand structure is shown as a gray ribbon. The fibril would grow by means of intermolecular 
H-bonding perpendicular to the plane of the image. 
 
 This arrangement will juxtapose one Glu-Lys pair and one histidine pair between strands so the 
structure will be stabilized by Glu-Lys salt bridges and - stacking interactions between 
histidines [134,135]. As a fraction of imidazole side chains will be protonated due to the close-
to-neutral pK = 6.30.1 [136], His-His attraction will be further strengthened by nucleophile-
electrophile interactions. This structure may grow laterally beyond tetramer until decreasing 
internal energy is compensated by decreasing entropy at a minimum of free energy. The fibril 
will grow by means of parallel -sheet formation stabilized by H-bonding perpendicular to the 
plane of side chains. The nonpolar overhangs may form turn or parallel -sheet structure 
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stabilized by hydrophobic interactions and - stacking interactions between C-terminal 
phenylalanines [134]. In order to test the model of P3 aggregation, assuming the interaction in 
stabilized by electrostatic forces. It can be tested it in two different ways:  
First, The observation of fibrillogenesis at low pH. At pH 3, the negative charge of Glu (pI 3.22) 
side chain will be neutralized and the Glu-Lys ionic bond will be eliminated.  
The second way would be using high salt concentration, such as a buffer containing same 
concentration of phosphate buffer and 1 M NaCl. Increase in salt concentration at 1.0 M caused a 
decrease in protein solubility. At very high salt concentrations, the increase in surface tension of 
water creates competition for hydration between protein and salt ions. Salt removes the necessary 
layer of water molecules from the surface of the protein and ultimately denatures the protein. 
In earlier observations of dimer formation by A10-23 peptide, it has exhibited that the peptide 
develops into -sheet fibrillar structure [137]. FTIR data (Figure 3.2.3d) show a low frequency 
(1623 cm-1) -sheet component without a high-frequency counterpart diagnostic for antiparallel 
-sheet, consistent with parallel -sheet formation. Figures 3.2.9, 3.2.10, and 3.2.11 show that P3 
forms fibrils and substantially blocks the fibrillogenesis of A1-42. Inhibition of A1-42 
fibrillogenesis presumably occurs through intercalation of P3 aggregates between A1-42 
molecules and/or binding of P3 to the homologous or other segments of A1-42. Consistent with 
our findings, it was reported earlier that A segment 11-17 (EVHHQKL), i.e. 0.7 part of P3, but 
not other A-derived short peptides, effectively blocked A1-40-induced Ca2+ influx into cultured 
cells possibly by inhibiting aggregation of A1-40 into a membrane pore-forming structure [129]. 
P3 is apparently able to bind not only to various parts of A but to other biomolecules as well. 
For example, the 12-18 stretch of A (VHHQKLV) has been found to bind to heparin and 
thereby mediate the effects of heparin on A plaque formation [138]. 
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 A region corresponding to P4 (A16-25) contains the central hydrophobic core 17-
LVFFA-21 that is deemed to be important for A aggregation. Molecular modeling and a variety 
of experimental studies have shown that the A16-22 fragment (KLVFFAE) forms antiparallel in-
register -sheet stabilized by nonpolar contacts between the central segment and ionic 
interactions between the side chains of N- and C-terminal Lys and Glu residues [123,128,139-
140]. Monomeric A16-25 was in coil or extended -strand-like conformation and transitioned 
into antiparallel -sheet through intermediate -helical structure [141]. Our data show unordered 
plus -strand conformation for P4 in HFIP in monomeric form (Figure 3.2.4e) but transition to 
-sheet in aqueous buffer is not observed (Figures 3.2.3e and 3.2.4e). This difference seemingly 
results from the supplementary three residues in P4 compared to A16-22. The presence of an 
additional anionic side chain of aspartic acid at position 23 results in excess negative charge and 
a low pI of 4.37 (Figure 3.2.1). These considerations suggest that long-range electrostatic 
repulsion between short peptides may interfere with initial peptide aggregation and subsequent 
fibrillization. Furthermore, an analogue of A16-22 with N-methyl amino acids in alternating 
positions was a potent inhibitor of A1-40 fibrillogenesis unlike the unmodified peptide [133], 
which is coherent with our data of negligible inhibitory effect of P4 on A1-42 fibril formation 
(Figures 3.2.10h and 3.2.11). 
 P5 encompasses the A region that forms a loop between two major -strands of A1-40 
fibrils characterized by two- or three-fold symmetry [94] and has been viewed as a folding 
nucleus for A 143,144]. This region is mostly in loop conformation in fibrils of A1-42 as well 
[118-120] (Figure 3.2.1). In complex with an affibody protein, A1-40 was found in a -hairpin 
conformation with residues 24-29 forming a loop between two -strands but without the Asp23-
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Lys28 salt bridge present in A1-40 fibrils of two-fold symmetry [145]. The isolated P5 segment 
itself was mostly unordered [83] or formed a loop with a central -turn structure formed by 
residues 24 and 27 and stabilized by ionic interactions of Lys28 with Glu22/Asp23 and nonpolar 
contacts between Val24 and Lys28 [143]. P5 did not undergo aggregation in aqueous medium 
[83,143], in accord with sequence-based calculation of low aggregation propensity. Transmission 
electron microscopic studies shown relatively large (25-120 nm) globular particles produced by 
P5 with uncapped termini whereas the N-acetylated/C-amidated peptide formed smaller 
particles, implying low aggregation tendency [144]. Our FTIR data for P5 display broad amide I 
band dominated by signal in the1670-1640 cm-1 range Figure 3.2.3f), revealing mostly 
unordered/turn structure of the peptide. This is confirmed by CD spectra with a deep minimum 
around 200 nm and a shallow negative band around 228 nm (Figure 3.2.4f). Figure 3.2.8e, h and 
3.2.7e, h display negligible light scattering and ThT fluorescence in P5 peptide samples, and 
Figures 3.2.10h and 3.2.11 document the inability of P5 to affect A1-42 fibrillogenesis, inferring 
a poor potency of P5 towards homo- or hetero-aggregation.  
P6 (A26-36) resembles the A25-35 peptide, which has been studied extensively due to its 
highly cytotoxic nature. In aqueous buffer at pH 4.0-5.5, the A25-35 peptide underwent 
concentration-dependent unordered-to--sheet transition whereas its C-amidated counterpart was 
in random coil state [146]. At close to neutral pH, the N-acetylated/C-amidated peptide attained 
β-sheet/β-turn structures [147]. In detergent micelles and in HFIP/water (80/20) environment, 
A25-35 was -helical in the C-terminal region and less ordered or turn conformation in the N-
terminus (25-28), and in HFIP/water (20/80) the C-terminus became unordered [148,149]. ThT 
and transmission electron microscopy assays revealed fibril formation by A25-35 [128,129] and 
-sheet breaking short peptides inhibited fibrillogenesis and cytotoxicity of the peptide [129]. 
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Slight sequence differences in this region of A resulted in significant differences in structural 
and aggregation properties. Biophysical and computational studies produced A26-36 and A25-35 
structural models as -hairpins containing two short -strands separated by a turn [112], in 
accord with our FTIR data (Figure 3.2.3g). P6 formed -sheet structure in aqueous buffer with 
red-shifted (~220 nm) n-* CD band and exhibited higher fibril formation capability than similar 
undecapeptides A25-35 and A24-34 [150], consistent with our results (Figures 3.2.4g and 3.27h).  
P7 (A31-42) represents the most hydrophobic C-terminal stretch of A and plays an 
important role in its aggregation into -sheet oligomers and fibrils [83,132]. Dynamic light 
scattering experiments identified two populations of A1-42 aggregates with hydrodynamic radii 
(RH) 8-12 nm and 20-60 nm, which upon elongated incubation in buffer exceeded 500 nm, while 
the P7 fragment formed large aggregates with RH around 100 nm [83,132]. In combination, P7 
affected the aggregation of A1-42 in a nontrivial way; it increased the abundance of larger 
particles but reduced the rate of their formation. Molecular modeling simulations showed that P7 
intercalates into A1-42 aggregates and thereby inhibits formation of toxic assemblies of A1-42 
[132]. The CD experiments showed that structural transitions of C-terminal fragments of A1-42 
were concentration dependent; at 62 M, P7 gradually transitioned from unordered state to -
sheet structure during 96 hours of incubation in buffer and formed fibrils [83], in very consistent 
with our finding (Figures 3.2.4h and 3.2.7g,h).  
 The characterization of the intrinsic aggregation and structural properties of overlapping 
peptide segments throughout the A1-42 sequence and the effects of these fragments on A1-42 
fibrillogenesis are done here. Though aforementioned studies have exploited a similar approach 
and have focused on certain parts of A1-42, such as the C-terminal hydrophobic stretch, 
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systematic dissection and analysis of the whole A1-42 sequence has not been reported. Or data 
identify A fragments that are capable of self-aggregation and -sheet structure formation and 
substantially inhibit fibrillogenesis of A1-42, presumably by intervention into forming 
aggregates or prevention of efficient intermolecular contacts between A1-42 molecules. 
However, the self-aggregation/-sheet propensities of the peptide fragments are not universally 
correlated to the inhibitory effect of fragments on A1-42 fibril formation. For example, P7, the 
most hydrophobic segment that undergoes efficient fibrilization (Figure 3.2.10h) and -sheet 
formation (Figures 3.2.3h and 3.2.4h) is a relatively week inhibitor of A1-42 fibrillization of 
(Figures 3.2.10h and 3.2.11). Finally based on our overall findings, it can be said that peptide 
fragments with high homo-aggregation propensity prefer self-association rather than forming 










CHAPTER 4: CONCLUSION 
Here, the first work aims to clarify the structural transformation of Aβ1-40 and pEAβ3-40 during 
fibril formation, either separately or in equimolar combination. Fluorescence data from ThT 
indicate that pEAβ3-40 rapidly forms a small fraction of fibers, which tend to grow slowly, and 
when combined with Aβ1-40, it can inhibit fibril formation. The CD data have shown that when 
dissolved in HFIP and in the dry state, both peptides exhibit an α-helix structure and are 
converted to a β-sheet structure in an aqueous buffer. Nevertheless, pEAβ3-40 acquired a unique 
conformation, possibly involving an α-helical structure. The combination of the two peptides 
exhibited a reduced fraction of the β sheet, consistent with the weaker ThT fluorescence. 
Isotope-edited FTIR spectroscopy analyzes the structural transition of each peptide when 
combined in a sample. The shifted frequency of amide I indicates that the unmodified and 
pyroglutamylated peptides form an intertwined structure and a mutual structural effect, that is, 
inhibition of the β-sheet / α-helix ratios. The FTIR data confirmed the retention of the residual α-
helical structure of pEAβ3-40 in individual and in the combined sample during hydration. Because 
mature fibrils are composed of cross β-sheet structure, the presence of heterogeneous secondary 
structures (including α-helix) will hinder fibril formation, as shown by ThT fluorescence data, 
and and will favor a longer lifetime for smaller assemblies that are known to be more toxic. 
Therefore, our data provide a molecular explanation for the hypertoxicity of pEAβ alone and in 
combination with unmodified Aβ. 
The second work has done based on the characterization the intrinsic aggregation and structural 
characteristics of overlapping peptides in the complete sequence of Aβ1-42, and the influence of 
these fragments on the formation of Aβ1-42 fibrils. FTIR data shows that the full-length A1-42 
exhibit -sheet and -turn/loop conformations in the presence aqueous environment, and it 
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indicates that the intermolecular H-bonding, formation of turn/loop structures which leads 
aggregation and fibrillogenesis. Where peptide fragments P3, P6, and P7 display -sheet 
structure where the other four peptides (P1, P2, P4, P5) incline to adopt −turn/loop 
conformations. The CD data established the findings of these peptide fragments, that P3, P6 and 
P7 stand out for showing a strong -sheet propensity, comparable to the parent peptide A1-42, 
whilst other peptides P1, P2, P4 and P5 incline to remain in -turn or disorderly conformation. 
ThT fluorescence and light scattering data provide evidence that, compared with the other four 
A peptide fragments, peptides P3, P6, and P7 have significant aggregation ability. Based on 
structural data, the aggregation/fibrillation properties of these peptides appear to be related to 
their ability to form -sheets. Fibrillogenesis of A1-42 was monitored in the absence and 
presence of all seven peptide fragments at two-fold molar excess to test the hypothesis of if 
certain peptide fragments exhibit a strong tendency to fibrillate, they may be able to be 
embedded in the full-length parent peptide segment by binding to the corresponding fragments to 
inhibit their aggregation. This observation indicates that P3 and P6 strongly inhibit A1-42 
fibrillation, in which peptides P2 and P7 show moderate inhibitory potency, while the other three 
peptides (P1, P4, and P5) are not effective inhibitors, indicating that all three peptides (P1, P4 
and P5) are not effective inhibitors and there is no universal correlation between them. Fragment 
self-aggregation / β-sheet tendency and inhibition of A1-42 fibril formation. However, effective 
inhibition of A1-42 aggregation by peptides P3 and P6 may help to develop new DNA, mRNA, 
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